<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2026"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:muzeu="http://MuzeroAcquisitionCorp.com/20260630"
  xmlns:srt="http://fasb.org/srt/2026"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="muzeu-20260630.xsd" xlink:type="simple"/>
    <context id="cref_278843630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_2122540640">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1335135677">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_583273791">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_148446753">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">muzeu:ImpliedClassASharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-02</instant>
        </period>
    </context>
    <context id="cref_109758591">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-02</instant>
        </period>
    </context>
    <context id="cref_1592048696">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">muzeu:ProbabilityOfDeSpacAndInstrumentSpecificMarketAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-02</instant>
        </period>
    </context>
    <context id="cref_1616795263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-02</instant>
        </period>
    </context>
    <context id="cref_1609687254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">muzeu:PublicWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_508943013">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">muzeu:PublicWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_655671550">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_6201542">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">muzeu:WarrantOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_765416459">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_479835142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">muzeu:WarrantOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1265451126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">muzeu:PrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_758136669">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">muzeu:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1581440693">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1503047126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1795270125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">muzeu:FounderShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-10-22</instant>
        </period>
    </context>
    <context id="cref_568168168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">muzeu:FounderShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-22</startDate>
            <endDate>2025-10-22</endDate>
        </period>
    </context>
    <context id="cref_1711580487">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-22</startDate>
            <endDate>2025-10-22</endDate>
        </period>
    </context>
    <context id="cref_349501735">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1267833943">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_2081978511">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1649110242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">muzeu:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_81139869">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">muzeu:PublicSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">muzeu:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_197171965">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">muzeu:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1056148756">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-02</startDate>
            <endDate>2026-02-02</endDate>
        </period>
    </context>
    <context id="cref_1532563924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1692292676">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_714186170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">muzeu:AdministrativeServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1216558862">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">muzeu:AdministrativeServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_162999191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">muzeu:AdministrativeServicesAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">muzeu:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1763374762">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">muzeu:AdministrativeServicesAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">muzeu:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-29</startDate>
            <endDate>2026-01-29</endDate>
        </period>
    </context>
    <context id="cref_271155247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_479704638">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_648891826">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">muzeu:PromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">muzeu:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_473022421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">muzeu:PromissoryNoteRelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">muzeu:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1488990682">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">muzeu:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">muzeu:FounderShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">muzeu:LetterAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_622567651">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">muzeu:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">muzeu:FounderShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-23</startDate>
            <endDate>2026-01-23</endDate>
        </period>
    </context>
    <context id="cref_581880427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">muzeu:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">muzeu:FounderShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-23</instant>
        </period>
    </context>
    <context id="cref_977868362">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">muzeu:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-22</startDate>
            <endDate>2025-10-22</endDate>
        </period>
    </context>
    <context id="cref_833084173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-02</instant>
        </period>
    </context>
    <context id="cref_990551864">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-02</instant>
        </period>
    </context>
    <context id="cref_886073356">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">muzeu:BTIGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-02</startDate>
            <endDate>2026-02-02</endDate>
        </period>
    </context>
    <context id="cref_1517094285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">muzeu:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-02</startDate>
            <endDate>2026-02-02</endDate>
        </period>
    </context>
    <context id="cref_1842533260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-02</startDate>
            <endDate>2026-02-02</endDate>
        </period>
    </context>
    <context id="cref_895700767">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-02</startDate>
            <endDate>2026-02-02</endDate>
        </period>
    </context>
    <context id="cref_95379054">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">muzeu:RedeemableWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-02</startDate>
            <endDate>2026-02-02</endDate>
        </period>
    </context>
    <context id="cref_2113638689">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-02</startDate>
            <endDate>2026-02-02</endDate>
        </period>
    </context>
    <context id="cref_362394658">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-02</instant>
        </period>
    </context>
    <context id="cref_1908234587">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_551350628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_769405443">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">muzeu:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1207725594">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1464180510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1668469061">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">muzeu:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1996996606">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_808443216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
        </entity>
        <period>
            <startDate>2026-02-02</startDate>
            <endDate>2026-02-02</endDate>
        </period>
    </context>
    <context id="cref_63099126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">muzeu:PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">muzeu:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-02</instant>
        </period>
    </context>
    <context id="cref_1692568167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">muzeu:TrustAccountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_21413446">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-02</instant>
        </period>
    </context>
    <context id="cref_1536667153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-02</instant>
        </period>
    </context>
    <context id="cref_295419154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">muzeu:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-02</startDate>
            <endDate>2026-02-02</endDate>
        </period>
    </context>
    <context id="cref_968188371">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">muzeu:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-02</startDate>
            <endDate>2026-02-02</endDate>
        </period>
    </context>
    <context id="cref_1664052813">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">muzeu:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-02</instant>
        </period>
    </context>
    <context id="cref_930588320">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">muzeu:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">muzeu:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-02</startDate>
            <endDate>2026-02-02</endDate>
        </period>
    </context>
    <context id="cref_1746159585">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_507600924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_250188696">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1101505803">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_68400826">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_3285224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_550976489">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_398061719">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_998330163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_803280537">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1429721485">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1849521390">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1426911310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_42937529">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_277585176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_490193678">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-13</instant>
        </period>
    </context>
    <context id="cref_116824011">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-13</instant>
        </period>
    </context>
    <context id="cref_355927059">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">muzeu:WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_640791560">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">muzeu:ClassAOrdinarySharesParValue00001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_2095181950">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">muzeu:UnitsEachConsistingOfOneClassAOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1365149847">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_935728785">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1133893187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1678289569">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_24014286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_2116066580">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_1993320521">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1002112534">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">muzeu:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_927690613">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">muzeu:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_218282246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_680511691">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1042947352">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1455913599">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002093484</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">muzeu:PrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <unit id="uref_1973205255">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="uref_148446753">
        <measure>pure</measure>
    </unit>
    <unit id="uref_1609687254">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="uref_1265451126">
        <measure>shares</measure>
    </unit>
    <unit id="uref_323860442">
        <measure>muzeu:Segment</measure>
    </unit>
    <dei:AmendmentFlag contextRef="cref_2122540640" id="ixv-4070">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="cref_2122540640" id="ixv-4071">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="cref_2122540640" id="ixv-4072">0002093484</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="cref_2122540640" id="ixv-4073">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:SharesOutstanding
      contextRef="cref_1365149847"
      id="fc_1365149847"
      unitRef="uref_1265451126"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_1365149847"
      id="fc_642089694"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_803280537"
      id="fc_353787749"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_935728785"
      id="fc_935728785"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_935728785"
      id="fc_995691432"
      unitRef="uref_1265451126"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_935728785"
      id="fc_1790904166"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_398061719"
      id="fc_1589312619"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="cref_803280537"
      id="fc_1920403742"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="cref_935728785"
      id="fc_2066066376"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="cref_398061719"
      id="fc_1284943170"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="cref_803280537"
      id="fc_468801285"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="cref_935728785"
      id="fc_1757798184"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="cref_398061719"
      id="fc_1314055564"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_803280537"
      id="fc_1098780887"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_935728785"
      id="fc_2005313810"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_998330163"
      id="fc_952883846"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_1133893187"
      id="fc_1133893187"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_1678289569"
      id="fc_1678289569"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_24014286"
      id="fc_24014286"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_2116066580"
      id="fc_2116066580"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1678289569"
      id="fc_1097145378"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_24014286"
      id="fc_1359902912"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_2116066580"
      id="fc_1948950956"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_1993320521"
      id="fc_1993320521"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_1002112534"
      id="fc_1002112534"
      unitRef="uref_1265451126"
      xsi:nil="true"/>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_927690613"
      id="fc_927690613"
      unitRef="uref_1265451126"
      xsi:nil="true"/>
    <us-gaap:AssetsHeldInTrust
      contextRef="cref_583273791"
      id="fc_1491498307"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="cref_1335135677"
      id="fc_1151603960"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="cref_583273791"
      id="fc_118597717"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="cref_1335135677"
      id="fc_309207806"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="cref_583273791"
      id="fc_1724534019"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="cref_583273791"
      id="fc_1215500778"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:LongTermInvestments
      contextRef="cref_583273791"
      id="fc_938340682"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="cref_42937529"
      id="fc_1989978289"
      unitRef="uref_1265451126"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_1335135677"
      id="fc_1083307648"
      unitRef="uref_1265451126"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_1335135677"
      id="fc_690338190"
      unitRef="uref_1265451126"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_583273791"
      id="fc_1068589011"
      unitRef="uref_1265451126"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_583273791"
      id="fc_1780590692"
      unitRef="uref_1265451126"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_42937529"
      id="fc_166911835"
      unitRef="uref_1265451126"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_42937529"
      id="fc_1906508171"
      unitRef="uref_1265451126"
      xsi:nil="true"/>
    <us-gaap:PrepaidInsurance
      contextRef="cref_583273791"
      id="fc_1691915543"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:DeferredCosts
      contextRef="cref_1335135677"
      id="fc_1890115685"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:AccountsPayableCurrent
      contextRef="cref_583273791"
      id="fc_658323334"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="cref_218282246"
      id="fc_218282246"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:NotesPayableCurrent
      contextRef="cref_218282246"
      id="fc_988827361"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <muzeu:DeferredFeePayable
      contextRef="cref_583273791"
      id="fc_689976312"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="cref_1335135677"
      id="fc_1610482655"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="cref_583273791"
      id="fc_1675496074"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="cref_1335135677"
      id="fc_681346666"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="cref_583273791"
      id="fc_2052966371"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="cref_42937529"
      id="fc_1962080825"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:AdditionalPaidInCapital
      contextRef="cref_1335135677"
      id="fc_1160621078"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="cref_583273791"
      id="fc_1616758625"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_680511691"
      id="fc_680511691"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:NumberOfReportableSegments
      contextRef="cref_2122540640"
      decimals="0"
      id="fc_323860442"
      unitRef="uref_323860442">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:AssetsHeldInTrust
      contextRef="cref_583273791"
      id="fc_875046747"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration contextRef="cref_2122540640" id="fc_665769053">http://fasb.org/srt/2026#ChiefExecutiveOfficerMember</us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration>
    <muzeu:WorkingCapitalLoansOutstanding
      contextRef="cref_2122540640"
      id="fc_739976744"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <muzeu:WorkingCapitalLoansOutstanding
      contextRef="cref_1042947352"
      id="fc_1042947352"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_42937529"
      id="fc_555309476"
      unitRef="uref_1265451126"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_42937529"
      id="fc_2092829611"
      unitRef="uref_1265451126"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="cref_42937529"
      id="fc_935895049"
      unitRef="uref_1265451126"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_1335135677"
      id="fc_1170507871"
      unitRef="uref_1265451126"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_583273791"
      id="fc_175899818"
      unitRef="uref_1265451126"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_1335135677"
      id="fc_1466601224"
      unitRef="uref_1265451126"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_583273791"
      id="fc_1634110681"
      unitRef="uref_1265451126"
      xsi:nil="true"/>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_1002112534"
      id="fc_112120139"
      unitRef="uref_1265451126"
      xsi:nil="true"/>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_1455913599"
      id="fc_1455913599"
      unitRef="uref_1265451126"
      xsi:nil="true"/>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="cref_2122540640"
      id="fc_404702570"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="cref_1042947352"
      id="fc_1697711111"
      unitRef="uref_1973205255"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="cref_2122540640" id="ixv-4936">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="cref_2122540640" id="ixv-4937">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="cref_2122540640" id="ixv-4938">2026-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus contextRef="cref_2122540640" id="ixv-4939">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="cref_2122540640" id="ixv-4940">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="cref_2122540640" id="ixv-4941">001-43091</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="cref_2122540640" id="ixv-4942">MUZERO     ACQUISITION CORP</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="cref_2122540640" id="ixv-4943">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="cref_2122540640" id="ixv-4944">98-1892892</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="cref_2122540640" id="fc_1075113021">136                                             Madison Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="cref_2122540640" id="ixv-4946">6th Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="cref_2122540640" id="ixv-4947">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="cref_2122540640" id="ixv-4948">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="cref_2122540640" id="ixv-4949">10016</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="cref_2122540640" id="ixv-4950">(646)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="cref_2122540640" id="ixv-4951">722-3311</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="cref_2095181950" id="ixv-4952">Units,     each consisting of one Class A Ordinary Share and one-half of one redeemable Warrant</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="cref_2095181950" id="ixv-4953">MUZEU</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="cref_2095181950" id="ixv-4954">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="cref_640791560" id="ixv-4955">Class     A Ordinary Shares, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="cref_640791560" id="ixv-4956">MUZE</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="cref_640791560" id="ixv-4957">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="cref_355927059" id="ixv-4958">Warrants,     each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="cref_355927059" id="ixv-4959">MUZEW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="cref_355927059" id="ixv-4960">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="cref_2122540640" id="ixv-4961">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="cref_2122540640" id="ixv-4962">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="cref_2122540640" id="ixv-4963">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="cref_2122540640" id="ixv-4964">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="cref_2122540640" id="ixv-4965">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="cref_2122540640" id="ixv-4966">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany contextRef="cref_2122540640" id="ixv-4967">true</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="cref_116824011"
      decimals="0"
      id="ixv-4968"
      unitRef="uref_1265451126">20611875</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="cref_490193678"
      decimals="0"
      id="ixv-4969"
      unitRef="uref_1265451126">6708333</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-4970"
      unitRef="uref_1973205255">839267</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="cref_583273791"
      decimals="0"
      id="ixv-4971"
      unitRef="uref_1973205255">69</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-4972"
      unitRef="uref_1973205255">53706</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="cref_583273791"
      decimals="0"
      id="ixv-4973"
      unitRef="uref_1973205255">3800</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:PrepaidInsurance
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-4974"
      unitRef="uref_1973205255">99719</us-gaap:PrepaidInsurance>
    <us-gaap:AssetsCurrent
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-4975"
      unitRef="uref_1973205255">992692</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="cref_583273791"
      decimals="0"
      id="ixv-4976"
      unitRef="uref_1973205255">3869</us-gaap:AssetsCurrent>
    <us-gaap:DeferredCosts
      contextRef="cref_583273791"
      decimals="0"
      id="ixv-4977"
      unitRef="uref_1973205255">195081</us-gaap:DeferredCosts>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-4978"
      unitRef="uref_1973205255">58169</us-gaap:PrepaidExpenseNoncurrent>
    <us-gaap:LongTermInvestments
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-4979"
      unitRef="uref_1973205255">204176777</us-gaap:LongTermInvestments>
    <us-gaap:Assets
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-4980"
      unitRef="uref_1973205255">205227638</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="cref_583273791"
      decimals="0"
      id="ixv-4981"
      unitRef="uref_1973205255">198950</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="cref_1335135677"
      decimals="0"
      id="fc_1262430542"
      unitRef="uref_1973205255">80000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-4983"
      unitRef="uref_1973205255">75000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="cref_583273791"
      decimals="0"
      id="ixv-4984"
      unitRef="uref_1973205255">77850</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="cref_277585176"
      decimals="0"
      id="ixv-4985"
      unitRef="uref_1973205255">641</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="cref_277585176"
      decimals="0"
      id="ixv-4986"
      unitRef="uref_1973205255">145000</us-gaap:NotesPayableCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-4987"
      unitRef="uref_1973205255">155000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="cref_583273791"
      decimals="0"
      id="ixv-4988"
      unitRef="uref_1973205255">223491</us-gaap:LiabilitiesCurrent>
    <muzeu:DeferredFeePayable
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-4989"
      unitRef="uref_1973205255">7043750</muzeu:DeferredFeePayable>
    <us-gaap:Liabilities
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-4990"
      unitRef="uref_1973205255">7198750</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="cref_583273791"
      decimals="0"
      id="ixv-4991"
      unitRef="uref_1973205255">223491</us-gaap:Liabilities>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="cref_2081978511"
      decimals="4"
      id="ixv-4992"
      unitRef="uref_1609687254">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="cref_42937529"
      decimals="4"
      id="ixv-4993"
      unitRef="uref_1609687254">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="cref_2081978511"
      decimals="0"
      id="ixv-4994"
      unitRef="uref_1265451126">20125000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="cref_2081978511"
      decimals="2"
      id="ixv-4995"
      unitRef="uref_1609687254">10.15</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="cref_42937529"
      decimals="0"
      id="ixv-4996"
      unitRef="uref_1609687254">0</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-4997"
      unitRef="uref_1973205255">204176777</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="cref_1335135677"
      decimals="4"
      id="ixv-4998"
      unitRef="uref_1609687254">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="cref_583273791"
      decimals="4"
      id="ixv-4999"
      unitRef="uref_1609687254">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-5000"
      unitRef="uref_1265451126">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="cref_583273791"
      decimals="0"
      id="ixv-5001"
      unitRef="uref_1265451126">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_2081978511"
      decimals="4"
      id="ixv-5002"
      unitRef="uref_1609687254">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_42937529"
      decimals="4"
      id="ixv-5003"
      unitRef="uref_1609687254">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_2081978511"
      decimals="0"
      id="ixv-5004"
      unitRef="uref_1265451126">450000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_42937529"
      decimals="0"
      id="ixv-5005"
      unitRef="uref_1265451126">450000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_2081978511"
      decimals="0"
      id="ixv-5006"
      unitRef="uref_1265451126">486875</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_2081978511"
      decimals="0"
      id="ixv-5007"
      unitRef="uref_1265451126">486875</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="cref_2081978511"
      decimals="0"
      id="ixv-5008"
      unitRef="uref_1973205255">49</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_1267833943"
      decimals="4"
      id="fc_522679048"
      unitRef="uref_1609687254">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_349501735"
      decimals="4"
      id="fc_186863080"
      unitRef="uref_1609687254">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_1267833943"
      decimals="0"
      id="fc_1596679236"
      unitRef="uref_1265451126">49000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_349501735"
      decimals="0"
      id="fc_2061447008"
      unitRef="uref_1265451126">49000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_1267833943"
      decimals="0"
      id="fc_1895070928"
      unitRef="uref_1265451126">6708333</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_349501735"
      decimals="0"
      id="fc_605294596"
      unitRef="uref_1265451126">6708333</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_1267833943"
      decimals="0"
      id="fc_1603811698"
      unitRef="uref_1265451126">6708333</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_349501735"
      decimals="0"
      id="fc_1602752913"
      unitRef="uref_1265451126">6708333</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="cref_1267833943"
      decimals="0"
      id="fc_123956521"
      unitRef="uref_1973205255">671</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="cref_349501735"
      decimals="0"
      id="fc_113126255"
      unitRef="uref_1973205255">671</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="cref_583273791"
      decimals="0"
      id="ixv-5019"
      unitRef="uref_1973205255">24329</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-5020"
      unitRef="uref_1973205255">-6148609</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="cref_583273791"
      decimals="0"
      id="ixv-5021"
      unitRef="uref_1973205255">-49541</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-5022"
      unitRef="uref_1973205255">-6147889</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_583273791"
      decimals="0"
      id="ixv-5023"
      unitRef="uref_1973205255">-24541</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-5024"
      unitRef="uref_1973205255">205227638</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="cref_583273791"
      decimals="0"
      id="ixv-5025"
      unitRef="uref_1973205255">198950</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="cref_1581440693"
      decimals="0"
      id="ixv-5027"
      unitRef="uref_1973205255">875000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="cref_1056148756"
      decimals="0"
      id="ixv-5028"
      unitRef="uref_1973205255">875000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_278843630"
      decimals="0"
      id="ixv-5029"
      unitRef="uref_1973205255">147265</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5030"
      unitRef="uref_1973205255">352495</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="cref_278843630"
      decimals="0"
      id="ixv-5031"
      unitRef="uref_1973205255">-147265</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5032"
      unitRef="uref_1973205255">-352495</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_278843630"
      decimals="0"
      id="ixv-5033"
      unitRef="uref_1973205255">1802635</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5034"
      unitRef="uref_1973205255">2926777</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestIncomeOther
      contextRef="cref_278843630"
      decimals="0"
      id="ixv-5035"
      unitRef="uref_1973205255">7760</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5036"
      unitRef="uref_1973205255">10339</us-gaap:InterestIncomeOther>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="cref_278843630"
      decimals="0"
      id="ixv-5037"
      unitRef="uref_1973205255">1810395</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5038"
      unitRef="uref_1973205255">2937116</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="cref_278843630"
      decimals="0"
      id="ixv-5039"
      unitRef="uref_1973205255">1663130</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5040"
      unitRef="uref_1973205255">2584621</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="cref_551350628"
      decimals="0"
      id="ixv-5041"
      unitRef="uref_1265451126">20611875</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="cref_765416459"
      decimals="0"
      id="ixv-5042"
      unitRef="uref_1265451126">16853909</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_551350628"
      decimals="2"
      id="ixv-5043"
      unitRef="uref_1609687254">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_765416459"
      decimals="2"
      id="ixv-5044"
      unitRef="uref_1609687254">0.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_551350628"
      decimals="0"
      id="ixv-5045"
      unitRef="uref_1265451126">20611875</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_765416459"
      decimals="0"
      id="ixv-5046"
      unitRef="uref_1265451126">16853909</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_551350628"
      decimals="2"
      id="ixv-5047"
      unitRef="uref_1609687254">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_765416459"
      decimals="2"
      id="ixv-5048"
      unitRef="uref_1609687254">0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="cref_1908234587"
      decimals="0"
      id="fc_529543847"
      unitRef="uref_1265451126">6708333</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="cref_1581440693"
      decimals="0"
      id="fc_1173920975"
      unitRef="uref_1265451126">6548803</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1908234587"
      decimals="2"
      id="ixv-5051"
      unitRef="uref_1609687254">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1581440693"
      decimals="2"
      id="ixv-5052"
      unitRef="uref_1609687254">0.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1908234587"
      decimals="0"
      id="fc_238064799"
      unitRef="uref_1265451126">6708333</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1581440693"
      decimals="0"
      id="fc_695229873"
      unitRef="uref_1265451126">6708333</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1908234587"
      decimals="2"
      id="ixv-5055"
      unitRef="uref_1609687254">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1581440693"
      decimals="2"
      id="ixv-5056"
      unitRef="uref_1609687254">0.11</us-gaap:EarningsPerShareDiluted>
    <muzeu:NumberOfForfeitedShares
      contextRef="cref_1503047126"
      decimals="0"
      id="ixv-5058"
      unitRef="uref_1265451126">875000</muzeu:NumberOfForfeitedShares>
    <muzeu:AdditionalSharesIssued
      contextRef="cref_930588320"
      decimals="0"
      id="fc_108657348"
      unitRef="uref_1265451126">875000</muzeu:AdditionalSharesIssued>
    <us-gaap:SharesOutstanding
      contextRef="cref_1426911310"
      decimals="0"
      id="fc_262493807"
      unitRef="uref_1265451126">6708333</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_1426911310"
      decimals="0"
      id="fc_1426911310"
      unitRef="uref_1973205255">671</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1849521390"
      decimals="0"
      id="ixv-5062"
      unitRef="uref_1973205255">24329</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1429721485"
      decimals="0"
      id="ixv-5063"
      unitRef="uref_1973205255">-49541</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_583273791"
      decimals="0"
      id="ixv-5064"
      unitRef="uref_1973205255">-24541</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_998330163"
      decimals="0"
      id="ixv-5065"
      unitRef="uref_1973205255">7643056</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_398061719"
      decimals="0"
      id="ixv-5066"
      unitRef="uref_1973205255">6881054</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_1464180510"
      decimals="0"
      id="ixv-5067"
      unitRef="uref_1973205255">14524110</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_803280537"
      decimals="0"
      id="ixv-5068"
      unitRef="uref_1265451126">486875</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_803280537"
      decimals="0"
      id="ixv-5069"
      unitRef="uref_1973205255">49</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_998330163"
      decimals="0"
      id="ixv-5070"
      unitRef="uref_1973205255">4868701</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_1464180510"
      decimals="0"
      id="ixv-5071"
      unitRef="uref_1973205255">4868750</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="cref_998330163"
      decimals="0"
      id="ixv-5072"
      unitRef="uref_1973205255">2918125</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="cref_1464180510"
      decimals="0"
      id="ixv-5073"
      unitRef="uref_1973205255">2918125</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="cref_998330163"
      decimals="0"
      id="ixv-5074"
      unitRef="uref_1973205255">168099</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="cref_1464180510"
      decimals="0"
      id="ixv-5075"
      unitRef="uref_1973205255">168099</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:NetIncomeLoss
      contextRef="cref_398061719"
      decimals="0"
      id="ixv-5076"
      unitRef="uref_1973205255">921491</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1464180510"
      decimals="0"
      id="ixv-5077"
      unitRef="uref_1973205255">921491</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="cref_550976489"
      decimals="0"
      id="ixv-5078"
      unitRef="uref_1265451126">486875</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_550976489"
      decimals="0"
      id="ixv-5079"
      unitRef="uref_1973205255">49</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="cref_3285224"
      decimals="0"
      id="fc_1950159288"
      unitRef="uref_1265451126">6708333</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_3285224"
      decimals="0"
      id="fc_3285224"
      unitRef="uref_1973205255">671</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_68400826"
      decimals="0"
      id="ixv-5082"
      unitRef="uref_1973205255">-6009104</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1207725594"
      decimals="0"
      id="ixv-5083"
      unitRef="uref_1973205255">-6008384</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_1101505803"
      decimals="0"
      id="ixv-5084"
      unitRef="uref_1973205255">1802635</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_278843630"
      decimals="0"
      id="ixv-5085"
      unitRef="uref_1973205255">1802635</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1101505803"
      decimals="0"
      id="ixv-5086"
      unitRef="uref_1973205255">1663130</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_278843630"
      decimals="0"
      id="ixv-5087"
      unitRef="uref_1973205255">1663130</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="cref_250188696"
      decimals="0"
      id="ixv-5088"
      unitRef="uref_1265451126">486875</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_250188696"
      decimals="0"
      id="ixv-5089"
      unitRef="uref_1973205255">49</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="cref_507600924"
      decimals="0"
      id="fc_1515654518"
      unitRef="uref_1265451126">6708333</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_507600924"
      decimals="0"
      id="fc_507600924"
      unitRef="uref_1973205255">671</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1746159585"
      decimals="0"
      id="ixv-5092"
      unitRef="uref_1973205255">-6148609</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-5093"
      unitRef="uref_1973205255">-6147889</us-gaap:StockholdersEquity>
    <muzeu:NumberOfForfeitedShares
      contextRef="cref_1503047126"
      decimals="0"
      id="ixv-5095"
      unitRef="uref_1265451126">875000</muzeu:NumberOfForfeitedShares>
    <muzeu:AdditionalSharesIssued
      contextRef="cref_930588320"
      decimals="0"
      id="ixv-5096"
      unitRef="uref_1265451126">875000</muzeu:AdditionalSharesIssued>
    <us-gaap:NetIncomeLoss
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5097"
      unitRef="uref_1973205255">2584621</us-gaap:NetIncomeLoss>
    <muzeu:PaymentOfOperationCostsDueToSponsor
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5098"
      unitRef="uref_1973205255">-16332</muzeu:PaymentOfOperationCostsDueToSponsor>
    <muzeu:RepaymentOfAdvancesFromRelatedParty
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5099"
      unitRef="uref_1973205255">16973</muzeu:RepaymentOfAdvancesFromRelatedParty>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5100"
      unitRef="uref_1973205255">2926777</us-gaap:InvestmentIncomeInterest>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5101"
      unitRef="uref_1973205255">49906</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <muzeu:IncreaseDecreaseInShortTermPrepaidInsurance
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5102"
      unitRef="uref_1973205255">99719</muzeu:IncreaseDecreaseInShortTermPrepaidInsurance>
    <muzeu:IncreaseDecreaseInLongTermPrepaidInsurance
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5103"
      unitRef="uref_1973205255">58169</muzeu:IncreaseDecreaseInLongTermPrepaidInsurance>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5104"
      unitRef="uref_1973205255">80000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5105"
      unitRef="uref_1973205255">-470591</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5106"
      unitRef="uref_1973205255">201250000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5107"
      unitRef="uref_1973205255">-201250000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <muzeu:ProceedsFromSaleOfPublicUnitsNetOfUnderwritingDiscountsPaid
      contextRef="cref_2122540640"
      decimals="0"
      id="fc_1639236035"
      unitRef="uref_1973205255">197728125</muzeu:ProceedsFromSaleOfPublicUnitsNetOfUnderwritingDiscountsPaid>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5109"
      unitRef="uref_1973205255">4868750</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <muzeu:UnderwriterReimbursement
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5110"
      unitRef="uref_1973205255">-503125</muzeu:UnderwriterReimbursement>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5111"
      unitRef="uref_1973205255">85000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5112"
      unitRef="uref_1973205255">230000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5113"
      unitRef="uref_1973205255">395211</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5114"
      unitRef="uref_1973205255">202559789</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5115"
      unitRef="uref_1973205255">839198</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_583273791"
      decimals="0"
      id="ixv-5116"
      unitRef="uref_1973205255">69</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-5117"
      unitRef="uref_1973205255">839267</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <muzeu:OfferingCostsIncludedInAccruedOfferingCosts
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5118"
      unitRef="uref_1973205255">75000</muzeu:OfferingCostsIncludedInAccruedOfferingCosts>
    <muzeu:DeferredFeePayables
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5119"
      unitRef="uref_1973205255">7043750</muzeu:DeferredFeePayables>
    <us-gaap:NatureOfOperations contextRef="cref_2122540640" id="ixv-2658">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;1 &#x2014;&#160;Organization and Business Operations&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Muzero Acquisition Corp (the &#x201c;Company&#x201d;) is a blank check company incorporated as a Cayman Islands exempted corporation on October&#160;10, 2025. The Company was incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar Business Combination with one or more businesses (the &#x201c;Business Combination&#x201d;). The Company has not selected any specific Business Combination target. As of June 30, 2026, the Company had not entered into a definitive agreement with any specific Business Combination target.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; As of June 30, 2026, the Company had not commenced any operations. All activity for the period from October&#160;10, 2025 (inception) through June 30, 2026 relates to the Company&#x2019;s formation, initial public offering (the &#x201c;Initial Public Offering&#x201d;), which is described below, and subsequent to the Initial Public Offering, efforts to identify a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December&#160;31 as its fiscal year end. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company&#x2019;s Sponsor is Muzero Acquisition Sponsors LLC (the &#x201c;Sponsor&#x201d;). The registration statement for the Company&#x2019;s Initial Public Offering was declared effective on January 29, 2026. On February 2, 2026, the Company consummated its initial public offering (&#x201c;Initial Public Offering&#x201d;), which consisted of 20,125,000 units (the &#x201c;Public Units&#x201d;), including the exercise in full by the Underwriters of an option to purchase up to 2,625,000 Units at the offering price to cover over-allotments. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $201,250,000. Each Unit consists of one Class A Ordinary Share, par value $0.0001 per share, of the Company, and one-half of one redeemable warrant (each, a &#x201c;Warrant&#x201d;) of the Company, with each whole Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $11.50 per share. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Simultaneously with the closing of the IPO, the Company consummated the sale of 486,875 units (the &#x201c;Private Placement Units&#x201d;) to the Sponsor and BTIG, LLC, the representative of the Underwriters, at $10.00 per Unit, generating gross proceeds of $4,868,750. Of those 486,875 Private Placement Units, the Sponsor purchased 335,938 Private Placement Units and BTIG, LLC purchased 150,937 Private Placement Units. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Transaction costs amounted to $10,649,942, consisting of $3,018,750 of cash underwriting fee (net of $503,125 Underwriters&#x2019; reimbursement), $7,043,750 of Deferred Fee, and $587,442 of other offering costs. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company&#x2019;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the Private Placement Units, although substantially all of the net proceeds are intended to be generally applied toward consummating a Business Combination (less deferred underwriting commissions). The Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the value of the assets held in the Trust Account (as defined below) (excluding the amount of deferred underwriting discounts held and taxes payable on the income earned on the Trust Account) at the time of signing an agreement to enter into a Business Combination. However, the Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act&#160;of&#160;1940, as amended (the &#x201c;Investment Company Act&#x201d;). There&#160;is no assurance that the Company will be able to successfully effect a Business Combination. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;  &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Following the closing of the Initial Public Offering on February 2, 2026, an amount of $201,250,000 ($10.00 per Unit) from the net proceeds of the sale of the Units, and a portion of the net proceeds from the sale of the Private Placement Units, was held in a Trust Account (the &#x201c;Trust Account&#x201d;) and may only be invested in U.S.&#160;government treasury obligations with a maturity of 185&#160;days or less or in money market funds meeting certain conditions under Rule&#160;2a-7 under the Investment Company Act, which invest only in direct U.S.&#160;government treasury obligations; the holding of these assets in this form is intended to be temporary and for the sole purpose of facilitating the intended business combination. To mitigate the risk that the Company might be deemed to be an investment company for purposes of the Investment Company Act, a risk that increases the longer that the Company holds investments in the Trust Account, the Company may, at any time (based on management team&#x2019;s ongoing assessment of all factors related to the potential status under the Investment Company Act), instruct the trustee to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in cash or in an interest bearing demand deposit account at a bank. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the proceeds from the Initial Public Offering and the sale of the Private Placement Units&#160;will not be released from the Trust Account until the earliest of (i)&#160;the completion of the Company&#x2019;s initial Business Combination, (ii)&#160;the redemption of the Company&#x2019;s Public Shares if the Company is unable to complete the initial Business Combination within 24&#160;months from the closing of the Initial Public Offering or by such earlier time as our board of directors may approve (the &#x201c;Combination Period&#x201d;), subject to applicable law, or (iii)&#160;the redemption of the Company&#x2019;s Public Shares properly submitted in connection with a shareholder vote to amend the Company&#x2019;s amended and restated memorandum and articles of association to (A)&#160;modify the substance or timing of the Company&#x2019;s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Company&#x2019;s Public Shares if the Company has not consummated an initial Business Combination within the Combination Period or (B)&#160;with respect to any other material provisions relating to shareholders&#x2019; rights or pre-initial Business Combination activity. The proceeds deposited in the Trust Account could become subject to the claims of the Company&#x2019;s creditors, if any, which could have priority over the claims of the Company&#x2019;s public shareholders. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company will provide the Company&#x2019;s public shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of the initial Business Combination either (i)&#160;in connection with a general meeting called to approve the initial Business Combination or (ii)&#160;without a shareholder vote by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed initial Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public shareholders will be entitled to redeem their shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two&#160;business&#160;days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account (less taxes payable), divided by the number of then outstanding Public Shares, subject to the limitations. As of June 30, 2026, the amount in the Trust Account is $10.15 per public share. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The ordinary shares subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Financial Accounting Standards Board&#x2019;s (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic&#160;480, &#x201c;Distinguishing Liabilities from Equity.&#x201d;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company will have only the duration of the Combination Period to complete the initial Business Combination. However, if the Company is unable to complete its initial Business Combination within the Combination Period, the Company will as promptly as reasonably possible but not more than ten&#160;business&#160;days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (less taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will constitute full and complete payment for the Public Shares and completely extinguish public shareholders&#x2019; rights as shareholders (including the right to receive further liquidation or other distributions, if any), subject to the Company&#x2019;s obligations under Cayman Islands law to provide for claims of creditors and subject to the other requirements of applicable law. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Sponsor, officers, directors and Advisors have entered into a letter agreement with the Company, pursuant to which they have agreed to (i)&#160;waive their redemption rights with respect to their Founder Shares, Private Placement Shares and Public Shares in connection with the completion of the initial Business Combination or an earlier redemption in connection with the commencement of the procedures to consummate the initial Business Combination if the Company determines it is desirable to facilitate the completion of the initial Business Combination; (ii)&#160;waive their redemption rights with respect to their Founder Shares, Private Placement Shares and Public Shares in connection with a shareholder vote to approve an amendment to the Company&#x2019;s amended and restated memorandum and articles of association; (iii)&#160;waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if the Company fails to complete the initial Business Combination within the Combination Period, although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete the initial Business Combination within the Combination Period and to liquidating distributions from assets outside the trust account; and (iv)&#160;vote any Founder Shares held by them and any Public Shares purchased during or after the Initial Public Offering (including in open market and privately-negotiated transactions) in favor of the initial Business Combination.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;  &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i)&#160;$10.00 per public share and (ii)&#160;the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00&#160;per&#160;share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company&#x2019;s indemnity of the Underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act&#160;of&#160;1933, as amended (the &#x201c;Securities Act&#x201d;). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor&#x2019;s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able to satisfy those obligations. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Liquidity, Capital Resources and Going Concern&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company&#x2019;s liquidity needs up to February 2, 2026 had been satisfied through the loan under an unsecured promissory note from the Sponsor of up to $300,000 (see Note 5) and a contribution of $25,000 from the Sponsor for the issuance of the Founder Shares, and after the IPO, through IPO proceeds and working capital. As of June 30, 2026, the Company had $839,267 in cash and had working capital of $837,692. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company&#x2019;s officers and directors may, but are not obligated to, loan the Company funds as may be required (&#x201c;Working Capital Loans&#x201d;). Such Working Capital Loans would be evidenced by one or more promissory notes. Those promissory notes may be repaid upon completion of a Business Combination, without interest, or, at the lender&#x2019;s discretion, up to $1,500,000 of the Working Capital Loans may be converted upon completion of a Business Combination into private units at a price of $10.00 per unit. Such private units would be identical to the Private Placement Units. In the event that a Business Combination does not close and the Company liquidates, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of June 30, 2026 and December 31, 2025, there were &lt;span style="-sec-ix-hidden:fc_739976744;"&gt;&lt;span style="-sec-ix-hidden:fc_1042947352;"&gt;no&lt;/span&gt;&lt;/span&gt; Working Capital Loans outstanding. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In connection with the Company&#x2019;s assessment of going concern considerations in accordance with FASB ASC 205-40, &#x201c;Presentation of Financial Statements - Going Concern,&#x201d; the Company does not believe it will need to raise additional funds in order to meet the expenditures required for operating its business. However, if the estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination is less than the actual amount necessary to do so, the Company may have insufficient funds available to operate its business prior to the initial Business Combination. The Company has the Combination Period to complete the initial Business Combination. Management has determined that the Company has sufficient funds to finance the working capital needs of the Company for one year from the date of issuance of the unaudited condensed financial statements.&lt;/p&gt;</us-gaap:NatureOfOperations>
    <muzeu:YearOfInception contextRef="cref_2122540640" id="ixv-5120">October&#160;10, 2025 (inception) through June 30, 2026</muzeu:YearOfInception>
    <muzeu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_968188371"
      decimals="0"
      id="ixv-5121"
      unitRef="uref_1265451126">20125000</muzeu:UnitsIssuedDuringPeriodSharesNewIssues>
    <muzeu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1056148756"
      decimals="0"
      id="ixv-5122"
      unitRef="uref_1265451126">2625000</muzeu:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1664052813"
      decimals="2"
      id="ixv-5123"
      unitRef="uref_1609687254">10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_968188371"
      decimals="0"
      id="ixv-5124"
      unitRef="uref_1973205255">201250000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <muzeu:NumberOfSharesInEachUnit
      contextRef="cref_295419154"
      decimals="0"
      id="ixv-5125"
      unitRef="uref_1265451126">1</muzeu:NumberOfSharesInEachUnit>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_1536667153"
      decimals="4"
      id="ixv-5126"
      unitRef="uref_1609687254">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SharePrice
      contextRef="cref_990551864"
      decimals="2"
      id="ixv-5127"
      unitRef="uref_1609687254">11.5</us-gaap:SharePrice>
    <muzeu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1842533260"
      decimals="0"
      id="ixv-5128"
      unitRef="uref_1265451126">486875</muzeu:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_21413446"
      decimals="2"
      id="ixv-5129"
      unitRef="uref_1609687254">10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="cref_1842533260"
      decimals="0"
      id="ixv-5130"
      unitRef="uref_1973205255">4868750</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <muzeu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1842533260"
      decimals="0"
      id="ixv-5131"
      unitRef="uref_1265451126">486875</muzeu:UnitsIssuedDuringPeriodSharesNewIssues>
    <muzeu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1517094285"
      decimals="0"
      id="ixv-5132"
      unitRef="uref_1265451126">335938</muzeu:UnitsIssuedDuringPeriodSharesNewIssues>
    <muzeu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_886073356"
      decimals="0"
      id="ixv-5133"
      unitRef="uref_1265451126">150937</muzeu:UnitsIssuedDuringPeriodSharesNewIssues>
    <muzeu:TransactionCosts
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-5134"
      unitRef="uref_1973205255">10649942</muzeu:TransactionCosts>
    <us-gaap:OtherUnderwritingExpense
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5135"
      unitRef="uref_1973205255">3018750</us-gaap:OtherUnderwritingExpense>
    <muzeu:UnderwritersReimbursement
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-5136"
      unitRef="uref_1973205255">503125</muzeu:UnderwritersReimbursement>
    <muzeu:DeferredUnderwritingFeesPayableNoncurrent
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-5137"
      unitRef="uref_1973205255">7043750</muzeu:DeferredUnderwritingFeesPayableNoncurrent>
    <muzeu:OtherOfferingCosts
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-5138"
      unitRef="uref_1973205255">587442</muzeu:OtherOfferingCosts>
    <muzeu:ProspectiveAssetsOfAcquireAsAPercentageOfFairValueOfAssetsInTheTrustAccount
      contextRef="cref_2122540640"
      decimals="2"
      id="ixv-5139"
      unitRef="uref_148446753">0.80</muzeu:ProspectiveAssetsOfAcquireAsAPercentageOfFairValueOfAssetsInTheTrustAccount>
    <muzeu:PercentageOfVotingSecuritiesAcquired
      contextRef="cref_2122540640"
      decimals="2"
      id="ixv-5140"
      unitRef="uref_148446753">0.50</muzeu:PercentageOfVotingSecuritiesAcquired>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_2113638689"
      decimals="0"
      id="ixv-5141"
      unitRef="uref_1973205255">201250000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_362394658"
      decimals="2"
      id="ixv-5142"
      unitRef="uref_1609687254">10</us-gaap:SaleOfStockPricePerShare>
    <muzeu:GovernmentInvestmentMaturityDays contextRef="cref_808443216" id="ixv-5143">P185D</muzeu:GovernmentInvestmentMaturityDays>
    <muzeu:PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination
      contextRef="cref_2122540640"
      decimals="2"
      id="ixv-5144"
      unitRef="uref_148446753">1</muzeu:PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination>
    <muzeu:PricePerPublicShare
      contextRef="cref_2122540640"
      decimals="2"
      id="ixv-5145"
      unitRef="uref_1609687254">10.15</muzeu:PricePerPublicShare>
    <muzeu:InterestToPayDissolutionExpenses
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5146"
      unitRef="uref_1973205255">100000</muzeu:InterestToPayDissolutionExpenses>
    <muzeu:PricePerPublicShare
      contextRef="cref_1692568167"
      decimals="2"
      id="ixv-5147"
      unitRef="uref_1609687254">10</muzeu:PricePerPublicShare>
    <us-gaap:SharePrice
      contextRef="cref_1335135677"
      decimals="2"
      id="ixv-5148"
      unitRef="uref_1609687254">10</us-gaap:SharePrice>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="cref_63099126"
      decimals="0"
      id="ixv-5149"
      unitRef="uref_1973205255">300000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="cref_808443216"
      decimals="0"
      id="ixv-5150"
      unitRef="uref_1973205255">25000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="cref_1335135677"
      decimals="0"
      id="fc_2040298788"
      unitRef="uref_1973205255">839267</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <muzeu:WorkingCapital
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-5152"
      unitRef="uref_1973205255">837692</muzeu:WorkingCapital>
    <muzeu:WorkingCapitalLoans
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5153"
      unitRef="uref_1973205255">1500000</muzeu:WorkingCapitalLoans>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1996996606"
      decimals="2"
      id="ixv-5154"
      unitRef="uref_1609687254">10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="cref_2122540640" id="ixv-2713">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Note 2 &#x2014; Summary of Significant Accounting Policies&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Basis of Presentation&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The accompanying unaudited condensed financial statements should be read in conjunction with the Company&#x2019;s Annual Report on Form 10-K for the fiscal period ended December 31, 2025, as filed with the SEC on March 27, 2026. The interim results for the three and six months ended June 30, 2026 are not necessarily indicative of the results to be expected for the year ending December 31, 2026 or for any future periods.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Emerging Growth Company Status&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company is an &#x201c;emerging growth company,&#x201d; as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart Our Business Startups Act&#160;of&#160;2012, (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Further, Section&#160;102(b)(1)&#160;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s unaudited condensed financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The preparation of the unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future events. Accordingly, the actual results could differ significantly from those estimates.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had cash of $4,267 and $69 and cash equivalents of $835,000 and $0 as of June 30, 2026 and December 31, 2025, respectively. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Investments Held in Trust Account&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; As of June 30, 2026, substantially all the assets held in the Trust Account, amounting to $204,176,777, which includes interest amounting to $2,926,777, of which $597,589 represents accrued interest as of June 30, 2026, and received on July 1, 2026, were held in money market funds, which are invested primarily in Treasury securities. All of the Company&#x2019;s investments held in the Trust Account are presented on the accompanying condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on investments held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. As of December 31, 2025, there were &lt;span style="-sec-ix-hidden:fc_1491498307;"&gt;no&lt;/span&gt; assets held in the Trust Account; assets were placed in the Trust Account at the closing of the Initial Public Offering. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#x2019;s financial condition, results of operations, and cash flows. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;  &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Offering Costs&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company complies with the requirements of the FASB ASC&#160;340-10-S99 and SEC Staff Accounting Bulletin (&#x201c;SAB&#x201d;) Topic&#160;5A&#160;&#x2014;&#160;&#x201c;Expenses of Offering.&#x201d; Offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC&#160;470-20, &#x201c;Debt with Conversion and Other Options,&#x201d; addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Public Units&#160;between Class&#160;A Ordinary Shares and Warrants, using the residual method by allocating Initial Public Offering proceeds first to assigned value of the Warrants and then to the Class&#160;A Ordinary Shares. Offering costs allocated to the Class&#160;A Ordinary Shares subject to possible redemption were charged to temporary equity, and offering costs allocated to the Warrants included in the Public Units&#160;and Private Placement Units&#160;were charged to shareholders&#x2019; deficit, as the Warrants, after management&#x2019;s evaluation, were accounted for under equity treatment.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under FASB ASC&#160;820, &#x201c;Fair Value Measurements and Disclosures,&#x201d; approximates the carrying amounts represented in the condensed balance sheets, primarily due to its short-term nature.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Warrant Instruments&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company accounts for the Warrants issued in connection with the Initial Public Offering and the private placement in accordance with the guidance contained in FASB ASC Topic&#160;815, &#x201c;Derivatives and Hedging.&#x201d; Accordingly, the Company evaluated and will classify the warrant instruments under equity treatment at their assigned values. There are 10,062,500 Public Warrants and 243,438 Private Placement Warrants currently outstanding as of June 30, 2026. There were &lt;span style="-sec-ix-hidden:fc_1002112534;"&gt;&lt;span style="-sec-ix-hidden:fc_927690613;"&gt;no&lt;/span&gt;&lt;/span&gt; Public Warrants and Private Placement Warrants as of December 31, 2025. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Class A Ordinary Shares Subject to Possible Redemption&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company&#x2019;s liquidation, or if there is a shareholder vote or tender offer in connection with the Company&#x2019;s initial Business Combination. In accordance with FASB ASC 480-10-S99, the Company classifies Public Shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and then to accumulated deficit. Accordingly, as of June 30, 2026, Class A Ordinary Shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#x2019; deficit section of the Company&#x2019;s condensed balance sheets. As of June 30, 2026, the Class A Ordinary Shares subject to possible redemption reflected in the condensed balance sheets are reconciled in the following table:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 88%; text-align: left;"&gt;Gross proceeds&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;201,250,000&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Less:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;Proceeds allocated to Public Warrants&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(2,918,125&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Class A Ordinary Shares issuance costs&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(10,481,843&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;Accretion of carrying value to redemption value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;14,524,110&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;Class A Ordinary Shares subject to possible redemption, March 31, 2026&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;202,374,142&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;Accretion of carrying value to redemption value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1,802,635&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Class A Ordinary Shares subject to possible redemption, June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;204,176,777&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company accounts for income taxes under ASC Topic&#160;740, &#x201c;Income Taxes,&#x201d; which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the unaudited condensed financial statements and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;  &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the unaudited condensed financial statements recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company&#x2019;s management determined that the Cayman Islands is the Company&#x2019;s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of June 30, 2026 and December 31, 2025, there were &lt;span style="-sec-ix-hidden:fc_1151603960;"&gt;&lt;span style="-sec-ix-hidden:fc_118597717;"&gt;no&lt;/span&gt;&lt;/span&gt; unrecognized tax benefits and &lt;span style="-sec-ix-hidden:fc_309207806;"&gt;&lt;span style="-sec-ix-hidden:fc_1724534019;"&gt;no&lt;/span&gt;&lt;/span&gt; amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United&#160;States. As such, the Company&#x2019;s tax provision was zero for the periods presented.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Net Income per Ordinary Share&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#x201c;Earnings Per Share.&#x201d; The Company has two classes of Ordinary Shares, Class A Ordinary Shares and Class B Ordinary Shares, par value $0.0001 (the &#x201c;Class B Ordinary Shares&#x201d;, and together with the Class A Ordinary Shares, the &#x201c;Ordinary Shares&#x201d;). Income and losses are shared pro rata between the two classes of Ordinary Shares. This presentation assumes a Business Combination as the most likely outcome. Net income per Ordinary Share is calculated by dividing the net income by the weighted average Ordinary Shares outstanding for the respective period. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The calculation of diluted net income per Ordinary Share does not consider the effect of the warrants issued in connection with the Initial Public Offering and the Private Placement to purchase an aggregate of 10,305,938 Class A Ordinary Shares in the calculation of diluted income per Ordinary Share, because their exercise is contingent upon future events. Accretion associated with the Class A Ordinary Shares subject to possible redemption is excluded from the calculation of earnings per Ordinary Share as the redemption value approximates fair value. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company has considered the effect of Class B Ordinary Shares that were excluded from weighted average number as they were contingent on the exercise of the Over-Allotment Option. Since the contingency was satisfied, the Company included these shares in the weighted average number as of the beginning of the interim period to determine the dilutive impact of these shares.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 14.55pt;"&gt;&#160;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The following table reflects the calculation of basic and diluted net income per Ordinary Share (in dollars, except per share amounts):&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;For the Three Months Ended&lt;br/&gt; June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;For the Six Months Ended&lt;br/&gt; June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Class A&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Class B&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Class A&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Class B&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-style: italic;"&gt;Basic net income per Ordinary Share&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 52%; text-align: left; text-indent: -4.7pt; padding-left: 4.7pt;"&gt;Allocation of net income&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,254,757&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;408,373&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,861,364&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;723,257&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-indent: -4.7pt; padding-left: 4.7pt;"&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="padding-bottom: 1.5pt; text-indent: -4.7pt; padding-left: 4.7pt;"&gt;Basic weighted average shares outstanding&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;20,611,875&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;6,708,333&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;16,853,909&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;6,548,803&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -4.7pt; padding-left: 4.7pt;"&gt;Basic net income per Ordinary Share&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;0.06&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;0.06&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;0.11&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;0.11&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 17.8pt;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;For the Three Months Ended&lt;br/&gt; June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;For the Six Months Ended&lt;br/&gt; June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Class A&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Class B&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Class A&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Class B&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-style: italic;"&gt;Diluted net income per Ordinary Share&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 52%; text-align: left; text-indent: -4.7pt; padding-left: 4.7pt;"&gt;Allocation of net income&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,254,757&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;408,373&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,848,762&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;735,859&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-indent: -4.7pt; padding-left: 4.7pt;"&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="padding-bottom: 1.5pt; text-indent: -4.7pt; padding-left: 4.7pt;"&gt;Diluted weighted average shares outstanding&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;20,611,875&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;6,708,333&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;16,853,909&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;6,708,333&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -4.7pt; padding-left: 4.7pt;"&gt;Diluted net income per Ordinary Share&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;0.06&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;0.06&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;0.11&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;0.11&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 17.8pt;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company&#x2019;s unaudited condensed financial statements.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="cref_2122540640" id="ixv-2718">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Basis of Presentation&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The accompanying unaudited condensed financial statements should be read in conjunction with the Company&#x2019;s Annual Report on Form 10-K for the fiscal period ended December 31, 2025, as filed with the SEC on March 27, 2026. The interim results for the three and six months ended June 30, 2026 are not necessarily indicative of the results to be expected for the year ending December 31, 2026 or for any future periods.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <muzeu:EmergingGrowthCompanyStatusPolicyTextBlock contextRef="cref_2122540640" id="ixv-2741">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Emerging Growth Company Status&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company is an &#x201c;emerging growth company,&#x201d; as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart Our Business Startups Act&#160;of&#160;2012, (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Further, Section&#160;102(b)(1)&#160;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s unaudited condensed financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt;</muzeu:EmergingGrowthCompanyStatusPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="cref_2122540640" id="ixv-2750">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The preparation of the unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future events. Accordingly, the actual results could differ significantly from those estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="cref_2122540640" id="ixv-2759">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had cash of $4,267 and $69 and cash equivalents of $835,000 and $0 as of June 30, 2026 and December 31, 2025, respectively. &lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:Cash
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-5155"
      unitRef="uref_1973205255">4267</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="cref_583273791"
      decimals="0"
      id="ixv-5156"
      unitRef="uref_1973205255">69</us-gaap:Cash>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-5157"
      unitRef="uref_1973205255">835000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="cref_583273791"
      decimals="0"
      id="ixv-5158"
      unitRef="uref_1973205255">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:InvestmentPolicyTextBlock contextRef="cref_2122540640" id="ixv-2766">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Investments Held in Trust Account&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; As of June 30, 2026, substantially all the assets held in the Trust Account, amounting to $204,176,777, which includes interest amounting to $2,926,777, of which $597,589 represents accrued interest as of June 30, 2026, and received on July 1, 2026, were held in money market funds, which are invested primarily in Treasury securities. All of the Company&#x2019;s investments held in the Trust Account are presented on the accompanying condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on investments held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. As of December 31, 2025, there were &lt;span style="-sec-ix-hidden:fc_1491498307;"&gt;no&lt;/span&gt; assets held in the Trust Account; assets were placed in the Trust Account at the closing of the Initial Public Offering. &lt;/p&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:AssetsHeldInTrust
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-5159"
      unitRef="uref_1973205255">204176777</us-gaap:AssetsHeldInTrust>
    <us-gaap:InterestReceivable
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-5160"
      unitRef="uref_1973205255">2926777</us-gaap:InterestReceivable>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-5161"
      unitRef="uref_1973205255">597589</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="cref_2122540640" id="ixv-2774">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#x2019;s financial condition, results of operations, and cash flows. &lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:FederalDepositInsuranceCorporationPremiumExpense
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5162"
      unitRef="uref_1973205255">250000</us-gaap:FederalDepositInsuranceCorporationPremiumExpense>
    <muzeu:OfferingCostsPolicyTextBlock contextRef="cref_2122540640" id="ixv-2790">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Offering Costs&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company complies with the requirements of the FASB ASC&#160;340-10-S99 and SEC Staff Accounting Bulletin (&#x201c;SAB&#x201d;) Topic&#160;5A&#160;&#x2014;&#160;&#x201c;Expenses of Offering.&#x201d; Offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC&#160;470-20, &#x201c;Debt with Conversion and Other Options,&#x201d; addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Public Units&#160;between Class&#160;A Ordinary Shares and Warrants, using the residual method by allocating Initial Public Offering proceeds first to assigned value of the Warrants and then to the Class&#160;A Ordinary Shares. Offering costs allocated to the Class&#160;A Ordinary Shares subject to possible redemption were charged to temporary equity, and offering costs allocated to the Warrants included in the Public Units&#160;and Private Placement Units&#160;were charged to shareholders&#x2019; deficit, as the Warrants, after management&#x2019;s evaluation, were accounted for under equity treatment.&lt;/p&gt;</muzeu:OfferingCostsPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="cref_2122540640" id="ixv-2797">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under FASB ASC&#160;820, &#x201c;Fair Value Measurements and Disclosures,&#x201d; approximates the carrying amounts represented in the condensed balance sheets, primarily due to its short-term nature.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <muzeu:WarrantInstrumentsPolicyTextBlock contextRef="cref_2122540640" id="ixv-2804">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Warrant Instruments&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company accounts for the Warrants issued in connection with the Initial Public Offering and the private placement in accordance with the guidance contained in FASB ASC Topic&#160;815, &#x201c;Derivatives and Hedging.&#x201d; Accordingly, the Company evaluated and will classify the warrant instruments under equity treatment at their assigned values. There are 10,062,500 Public Warrants and 243,438 Private Placement Warrants currently outstanding as of June 30, 2026. There were &lt;span style="-sec-ix-hidden:fc_1002112534;"&gt;&lt;span style="-sec-ix-hidden:fc_927690613;"&gt;no&lt;/span&gt;&lt;/span&gt; Public Warrants and Private Placement Warrants as of December 31, 2025. &lt;/p&gt;</muzeu:WarrantInstrumentsPolicyTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_758136669"
      decimals="0"
      id="ixv-5163"
      unitRef="uref_1265451126">10062500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_1668469061"
      decimals="0"
      id="ixv-5164"
      unitRef="uref_1265451126">243438</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock contextRef="cref_2122540640" id="fc_1593722036">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Class A Ordinary Shares Subject to Possible Redemption&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company&#x2019;s liquidation, or if there is a shareholder vote or tender offer in connection with the Company&#x2019;s initial Business Combination. In accordance with FASB ASC 480-10-S99, the Company classifies Public Shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and then to accumulated deficit. Accordingly, as of June 30, 2026, Class A Ordinary Shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#x2019; deficit section of the Company&#x2019;s condensed balance sheets. As of June 30, 2026, the Class A Ordinary Shares subject to possible redemption reflected in the condensed balance sheets are reconciled in the following table:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 88%; text-align: left;"&gt;Gross proceeds&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;201,250,000&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Less:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;Proceeds allocated to Public Warrants&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(2,918,125&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Class A Ordinary Shares issuance costs&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(10,481,843&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;Accretion of carrying value to redemption value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;14,524,110&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;Class A Ordinary Shares subject to possible redemption, March 31, 2026&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;202,374,142&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;Accretion of carrying value to redemption value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1,802,635&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Class A Ordinary Shares subject to possible redemption, June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;204,176,777&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock>
    <us-gaap:TemporaryEquityTableTextBlock contextRef="cref_2122540640" id="ixv-5165">As of June 30, 2026, the Class A Ordinary Shares subject to possible redemption reflected in the condensed balance sheets are reconciled in the following table:&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 88%; text-align: left;"&gt;Gross proceeds&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;201,250,000&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Less:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;Proceeds allocated to Public Warrants&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(2,918,125&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Class A Ordinary Shares issuance costs&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(10,481,843&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;Accretion of carrying value to redemption value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;14,524,110&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;Class A Ordinary Shares subject to possible redemption, March 31, 2026&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;202,374,142&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;Accretion of carrying value to redemption value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;1,802,635&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Class A Ordinary Shares subject to possible redemption, June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;204,176,777&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:TemporaryEquityTableTextBlock>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="cref_1464180510"
      decimals="0"
      id="ixv-5166"
      unitRef="uref_1973205255">201250000</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="cref_1464180510"
      decimals="0"
      id="ixv-5167"
      unitRef="uref_1973205255">2918125</us-gaap:ProceedsFromIssuanceOfWarrants>
    <muzeu:ClassAOrdinarySharesIssuanceAtCost
      contextRef="cref_1464180510"
      decimals="0"
      id="ixv-5168"
      unitRef="uref_1973205255">-10481843</muzeu:ClassAOrdinarySharesIssuanceAtCost>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_1464180510"
      decimals="0"
      id="ixv-5169"
      unitRef="uref_1973205255">14524110</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="cref_1207725594"
      decimals="0"
      id="ixv-5170"
      unitRef="uref_1973205255">202374142</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_278843630"
      decimals="0"
      id="ixv-5171"
      unitRef="uref_1973205255">1802635</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-5172"
      unitRef="uref_1973205255">204176777</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="cref_2122540640" id="ixv-2884">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company accounts for income taxes under ASC Topic&#160;740, &#x201c;Income Taxes,&#x201d; which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the unaudited condensed financial statements and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;  &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the unaudited condensed financial statements recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company&#x2019;s management determined that the Cayman Islands is the Company&#x2019;s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of June 30, 2026 and December 31, 2025, there were &lt;span style="-sec-ix-hidden:fc_1151603960;"&gt;&lt;span style="-sec-ix-hidden:fc_118597717;"&gt;no&lt;/span&gt;&lt;/span&gt; unrecognized tax benefits and &lt;span style="-sec-ix-hidden:fc_309207806;"&gt;&lt;span style="-sec-ix-hidden:fc_1724534019;"&gt;no&lt;/span&gt;&lt;/span&gt; amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United&#160;States. As such, the Company&#x2019;s tax provision was zero for the periods presented.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="cref_2122540640" id="ixv-2905">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Net Income per Ordinary Share&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#x201c;Earnings Per Share.&#x201d; The Company has two classes of Ordinary Shares, Class A Ordinary Shares and Class B Ordinary Shares, par value $0.0001 (the &#x201c;Class B Ordinary Shares&#x201d;, and together with the Class A Ordinary Shares, the &#x201c;Ordinary Shares&#x201d;). Income and losses are shared pro rata between the two classes of Ordinary Shares. This presentation assumes a Business Combination as the most likely outcome. Net income per Ordinary Share is calculated by dividing the net income by the weighted average Ordinary Shares outstanding for the respective period. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The calculation of diluted net income per Ordinary Share does not consider the effect of the warrants issued in connection with the Initial Public Offering and the Private Placement to purchase an aggregate of 10,305,938 Class A Ordinary Shares in the calculation of diluted income per Ordinary Share, because their exercise is contingent upon future events. Accretion associated with the Class A Ordinary Shares subject to possible redemption is excluded from the calculation of earnings per Ordinary Share as the redemption value approximates fair value. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company has considered the effect of Class B Ordinary Shares that were excluded from weighted average number as they were contingent on the exercise of the Over-Allotment Option. Since the contingency was satisfied, the Company included these shares in the weighted average number as of the beginning of the interim period to determine the dilutive impact of these shares.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 14.55pt;"&gt;&#160;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The following table reflects the calculation of basic and diluted net income per Ordinary Share (in dollars, except per share amounts):&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;For the Three Months Ended&lt;br/&gt; June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;For the Six Months Ended&lt;br/&gt; June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Class A&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Class B&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Class A&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Class B&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-style: italic;"&gt;Basic net income per Ordinary Share&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 52%; text-align: left; text-indent: -4.7pt; padding-left: 4.7pt;"&gt;Allocation of net income&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,254,757&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;408,373&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,861,364&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;723,257&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-indent: -4.7pt; padding-left: 4.7pt;"&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="padding-bottom: 1.5pt; text-indent: -4.7pt; padding-left: 4.7pt;"&gt;Basic weighted average shares outstanding&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;20,611,875&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;6,708,333&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;16,853,909&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;6,548,803&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -4.7pt; padding-left: 4.7pt;"&gt;Basic net income per Ordinary Share&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;0.06&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;0.06&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;0.11&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;0.11&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 17.8pt;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;For the Three Months Ended&lt;br/&gt; June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;For the Six Months Ended&lt;br/&gt; June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Class A&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Class B&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Class A&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Class B&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-style: italic;"&gt;Diluted net income per Ordinary Share&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 52%; text-align: left; text-indent: -4.7pt; padding-left: 4.7pt;"&gt;Allocation of net income&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,254,757&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;408,373&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,848,762&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;735,859&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-indent: -4.7pt; padding-left: 4.7pt;"&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="padding-bottom: 1.5pt; text-indent: -4.7pt; padding-left: 4.7pt;"&gt;Diluted weighted average shares outstanding&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;20,611,875&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;6,708,333&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;16,853,909&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;6,708,333&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -4.7pt; padding-left: 4.7pt;"&gt;Diluted net income per Ordinary Share&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;0.06&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;0.06&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;0.11&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;0.11&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_1267833943"
      decimals="4"
      id="ixv-5173"
      unitRef="uref_1609687254">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_769405443"
      decimals="0"
      id="ixv-5174"
      unitRef="uref_1265451126">10305938</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="cref_2122540640" id="ixv-2917">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The following table reflects the calculation of basic and diluted net income per Ordinary Share (in dollars, except per share amounts):&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;For the Three Months Ended&lt;br/&gt; June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;For the Six Months Ended&lt;br/&gt; June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Class A&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Class B&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Class A&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Class B&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-style: italic;"&gt;Basic net income per Ordinary Share&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 52%; text-align: left; text-indent: -4.7pt; padding-left: 4.7pt;"&gt;Allocation of net income&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,254,757&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;408,373&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,861,364&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;723,257&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-indent: -4.7pt; padding-left: 4.7pt;"&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="padding-bottom: 1.5pt; text-indent: -4.7pt; padding-left: 4.7pt;"&gt;Basic weighted average shares outstanding&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;20,611,875&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;6,708,333&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;16,853,909&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;6,548,803&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -4.7pt; padding-left: 4.7pt;"&gt;Basic net income per Ordinary Share&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;0.06&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;0.06&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;0.11&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;0.11&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 17.8pt;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;For the Three Months Ended&lt;br/&gt; June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;For the Six Months Ended&lt;br/&gt; June 30, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Class A&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Class B&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Class A&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Class B&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-style: italic;"&gt;Diluted net income per Ordinary Share&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 52%; text-align: left; text-indent: -4.7pt; padding-left: 4.7pt;"&gt;Allocation of net income&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,254,757&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;408,373&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,848,762&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;735,859&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-indent: -4.7pt; padding-left: 4.7pt;"&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="padding-bottom: 1.5pt; text-indent: -4.7pt; padding-left: 4.7pt;"&gt;Diluted weighted average shares outstanding&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;20,611,875&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;6,708,333&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;16,853,909&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;6,708,333&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -4.7pt; padding-left: 4.7pt;"&gt;Diluted net income per Ordinary Share&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;0.06&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;0.06&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;0.11&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;0.11&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_551350628"
      decimals="0"
      id="ixv-5175"
      unitRef="uref_1973205255">1254757</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_1908234587"
      decimals="0"
      id="ixv-5176"
      unitRef="uref_1973205255">408373</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_765416459"
      decimals="0"
      id="ixv-5177"
      unitRef="uref_1973205255">1861364</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_1581440693"
      decimals="0"
      id="ixv-5178"
      unitRef="uref_1973205255">723257</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_551350628"
      decimals="0"
      id="ixv-5179"
      unitRef="uref_1265451126">20611875</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1908234587"
      decimals="0"
      id="ixv-5180"
      unitRef="uref_1265451126">6708333</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_765416459"
      decimals="0"
      id="ixv-5181"
      unitRef="uref_1265451126">16853909</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1581440693"
      decimals="0"
      id="ixv-5182"
      unitRef="uref_1265451126">6548803</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_551350628"
      decimals="2"
      id="ixv-5183"
      unitRef="uref_1609687254">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1908234587"
      decimals="2"
      id="ixv-5184"
      unitRef="uref_1609687254">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_765416459"
      decimals="2"
      id="ixv-5185"
      unitRef="uref_1609687254">0.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1581440693"
      decimals="2"
      id="ixv-5186"
      unitRef="uref_1609687254">0.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="cref_551350628"
      decimals="0"
      id="ixv-5187"
      unitRef="uref_1973205255">1254757</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="cref_1908234587"
      decimals="0"
      id="ixv-5188"
      unitRef="uref_1973205255">408373</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="cref_765416459"
      decimals="0"
      id="ixv-5189"
      unitRef="uref_1973205255">1848762</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="cref_1581440693"
      decimals="0"
      id="ixv-5190"
      unitRef="uref_1973205255">735859</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_551350628"
      decimals="0"
      id="ixv-5191"
      unitRef="uref_1265451126">20611875</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1908234587"
      decimals="0"
      id="ixv-5192"
      unitRef="uref_1265451126">6708333</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_765416459"
      decimals="0"
      id="ixv-5193"
      unitRef="uref_1265451126">16853909</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1581440693"
      decimals="0"
      id="ixv-5194"
      unitRef="uref_1265451126">6708333</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_551350628"
      decimals="2"
      id="ixv-5195"
      unitRef="uref_1609687254">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1908234587"
      decimals="2"
      id="ixv-5196"
      unitRef="uref_1609687254">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_765416459"
      decimals="2"
      id="ixv-5197"
      unitRef="uref_1609687254">0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1581440693"
      decimals="2"
      id="ixv-5198"
      unitRef="uref_1609687254">0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="cref_2122540640" id="ixv-3174">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company&#x2019;s unaudited condensed financial statements.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <muzeu:InitialPublicOfferingTextBlock contextRef="cref_2122540640" id="ixv-3189">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;3 &#x2014;&#160;Initial Public Offering&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; In connection with the closing of the Initial Public Offering, the Company sold 20,125,000&#160;Units, which includes the full exercise of the Underwriters&#x2019; Over-Allotment Option at a purchase price of $10.00 per Unit, generating gross proceeds of $201,250,000. Each Unit consists of one Class&#160;A Ordinary Share and one-half of one redeemable Warrant. Each whole Warrant will entitle the holder to purchase one Class&#160;A Ordinary Share at a price of $11.50 per share, subject to adjustment. Each Warrant will become exercisable 30&#160;days after the completion of the initial Business Combination and will expire five&#160;years after the completion of the initial Business Combination, or earlier upon redemption or liquidation. &lt;/p&gt;</muzeu:InitialPublicOfferingTextBlock>
    <muzeu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_2113638689"
      decimals="0"
      id="ixv-5199"
      unitRef="uref_1265451126">20125000</muzeu:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_362394658"
      decimals="2"
      id="ixv-5200"
      unitRef="uref_1609687254">10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_2113638689"
      decimals="0"
      id="ixv-5201"
      unitRef="uref_1973205255">201250000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <muzeu:NumberOfSharesIssuedPerUnit
      contextRef="cref_895700767"
      decimals="0"
      id="ixv-5202"
      unitRef="uref_1265451126">1</muzeu:NumberOfSharesIssuedPerUnit>
    <muzeu:NumberOfSharesIssuedPerUnit
      contextRef="cref_95379054"
      decimals="0"
      id="ixv-5203"
      unitRef="uref_1265451126">1</muzeu:NumberOfSharesIssuedPerUnit>
    <muzeu:NumberOfSharesIssuedPerUnit
      contextRef="cref_895700767"
      decimals="0"
      id="ixv-5204"
      unitRef="uref_1265451126">1</muzeu:NumberOfSharesIssuedPerUnit>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_990551864"
      decimals="2"
      id="ixv-5205"
      unitRef="uref_1609687254">11.5</us-gaap:SaleOfStockPricePerShare>
    <muzeu:PrivatePlacementTextBlock contextRef="cref_2122540640" id="ixv-3196">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;4 &#x2014;&#160;Private Placement&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Simultaneously with the closing of the Initial Public Offering, the Sponsor and BTIG purchased an aggregate of 486,875 Private Placement Units, generating gross proceeds of $4,868,750. Of those 486,875 Private Placement Units, the Sponsor purchased 335,938 Private Placement Units&#160;and BTIG purchased 150,937 Private Placement Units. Each whole warrant entitles the registered holder to purchase one Class&#160;A Ordinary Share at a price of $11.50 per share, subject to adjustment. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Private Placement Units&#160;are identical to the Public Units&#160;sold in the Initial Public Offering except that, so long as they are held by the Sponsor, the Underwriters or their permitted transferees, the Private Placement Units&#160;(i)&#160;may not (including the Class&#160;A Ordinary Shares issuable upon exercise of the warrants contained in the Private Placement Units), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30&#160;days after the completion of the initial Business Combination, (ii)&#160;will be entitled to registration rights and (iii)&#160;with respect to Private Placement Warrants contained in the Private Placement Units&#160;held by the Underwriters and/or their designees, will not be exercisable more than five&#160;years from the commencement of sales in the Initial Public Offering in accordance with FINRA Rule&#160;5110(g)(8). &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Sponsor and the Company&#x2019;s officers, directors and Advisors have entered into a letter agreement with the Company, pursuant to which they have agreed to (i)&#160;waive their redemption rights with respect to their Founder Shares, Private Placement Shares and Public Shares in connection with the completion of the initial Business Combination or an earlier redemption in connection with the commencement of the procedures to consummate the initial Business Combination if the Company determines it is desirable to facilitate the completion of the initial Business Combination; (ii)&#160;waive their redemption rights with respect to their Founder Shares, Private Placement Shares and Public Shares in connection with a shareholder vote to approve an amendment to the Company&#x2019;s amended and restated memorandum and articles of association (A)&#160;to modify the substance or timing of the Company&#x2019;s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Public Shares if the Company has not consummated an initial Business Combination within the Combination Period or (B)&#160;with respect to any other material provisions relating to shareholders&#x2019; rights or pre-initial Business Combination activity; (iii)&#160;waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares and Private Placement Shares if the Company fails to complete the initial Business Combination within the Combination Period, although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete the initial Business Combination within the Combination Period and to liquidating distributions from assets outside the trust account; and (iv)&#160;vote any Founder Shares held by them and any Public Shares purchased during or after the Initial Public Offering (including in open market and privately-negotiated transactions) in favor of the initial Business Combination. &lt;/p&gt;</muzeu:PrivatePlacementTextBlock>
    <muzeu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1842533260"
      decimals="0"
      id="ixv-5206"
      unitRef="uref_1265451126">486875</muzeu:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="cref_1842533260"
      decimals="0"
      id="ixv-5207"
      unitRef="uref_1973205255">4868750</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <muzeu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1842533260"
      decimals="0"
      id="ixv-5208"
      unitRef="uref_1265451126">486875</muzeu:UnitsIssuedDuringPeriodSharesNewIssues>
    <muzeu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1517094285"
      decimals="0"
      id="ixv-5209"
      unitRef="uref_1265451126">335938</muzeu:UnitsIssuedDuringPeriodSharesNewIssues>
    <muzeu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_886073356"
      decimals="0"
      id="ixv-5210"
      unitRef="uref_1265451126">150937</muzeu:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="cref_990551864"
      decimals="0"
      id="ixv-5211"
      unitRef="uref_1265451126">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_833084173"
      decimals="2"
      id="ixv-5212"
      unitRef="uref_1609687254">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <muzeu:AfterTheInitialBusinessCombinationDays contextRef="cref_2122540640" id="ixv-5213">P30D</muzeu:AfterTheInitialBusinessCombinationDays>
    <muzeu:PercentageOfPublicShares
      contextRef="cref_2122540640"
      decimals="2"
      id="ixv-5214"
      unitRef="uref_148446753">1</muzeu:PercentageOfPublicShares>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="cref_2122540640" id="ixv-3206">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;5 &#x2014;&#160;Related Party Transactions&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Founder Shares&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On October&#160;22, 2025, the Company issued an aggregate of 6,708,333 Class&#160;B Ordinary Shares, $0.0001 par value (the &#x201c;Founder Shares&#x201d;), in exchange for a $25,000 payment (approximately $0.004 per share) from the Sponsor to cover certain expenses on behalf of the Company. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; On January 23, 2026, the Sponsor assigned and transferred indirect interests in an aggregate of 280,000 Founder Shares to independent directors and officers and Advisors. All assignments and transfers are in exchange for their services as directors and officers and Advisors through the Company&#x2019;s initial Business Combination. The indirect interests in the Founder Shares shall return to the Sponsor if the director, officer or Advisor is no longer serving the Company on or prior to the initial Business Combination. The transfer of indirect interests in Founder Shares to the independent directors and officers and Advisors is in the scope of FASB ASC Topic 718, &#x201c;Compensation-Stock Compensation&#x201d; (&#x201c;ASC 718&#x201d;). Under ASC 718, stock-based compensation associated with equity classified awards is measured at fair value upon the assignment date. The total fair value of the 280,000 Founder Shares in which interests were transferred to the directors and officers and Advisors was $688,800 or $2.46 per share. The Company established the initial fair value of the Founder Shares on January 23, 2026, using a calculation prepared by a third party valuation team which takes into consideration the implied share price of $9.85 and probability of de-SPAC and instrument-specific market adjustment of 25.0%. Stock-based compensation would be recognized at the date a Business Combination is considered probable (i.e., upon consummation of a Business Combination) in an amount equal to the number of Founder Shares that ultimately vest times the assignment date fair value per share (unless subsequently modified) less the amount initially received for the transfer of Founder Shares. As of June 30, 2026 and December 31, 2025, the Company determined that the initial Business Combination is not considered probable and therefore &lt;span style="-sec-ix-hidden:fc_404702570;"&gt;&lt;span style="-sec-ix-hidden:fc_1697711111;"&gt;no&lt;/span&gt;&lt;/span&gt; compensation expense has been recognized. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;       &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company&#x2019;s initial shareholders have agreed not to transfer, assign or sell any of their Founder Shares and any Class&#160;A Ordinary Shares issued upon conversion thereof until the earlier to occur of (i)&#160;six&#160;months after the completion of the initial Business Combination or (ii)&#160;the date on which the Company completes a liquidation, merger, share exchange or other similar transaction after the initial Business Combination that results in all of the Company&#x2019;s shareholders having the right to exchange their Class&#160;A Ordinary Shares for cash, securities or other property. Any permitted transferees will be subject to the same restrictions and other agreements of the Company&#x2019;s initial shareholders with respect to any Founder Shares (the &#x201c;Lock-up&#x201d;). Notwithstanding the foregoing, if (1)&#160;the closing price of the Class&#160;A Ordinary Shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20&#160;trading&#160;days within any 30-trading&#160;day period commencing at least 30&#160;days after our initial Business Combination or (2) the Company consummates a transaction after the initial Business Combination which results in the Company&#x2019;s shareholders having the right to exchange their shares for cash, securities or other property, the Founder Shares will be released from the Lock-up. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Promissory Note&#160;&#x2014;&#160;Related Party&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Sponsor had agreed to loan the Company an aggregate of up to $300,000 to be used for a portion of the expenses of the Initial Public Offering. The loan is non-interest bearing, unsecured and due at the earlier of (i)&#160;December&#160;31, 2026 or (ii)&#160;the closing date of the Initial Public Offering. The Company had borrowed $230,000 under the Promissory Note, which was repaid at the closing of the Initial Public Offering on February 2, 2026. Borrowings under the Promissory Note are no longer available. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Advances from&#160;Related Party&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; As of June 30, 2026 and December 31, 2025, the Company owes $0 and $641 to a related party for expenses which it has paid on the Company&#x2019;s behalf, respectively. The amount is due on demand. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Administrative Services Agreement&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Pursuant to the Administrative Services Agreement dated January 29, 2026, the Company entered into an agreement with an affiliate of the Sponsor to pay an aggregate of $15,000 per month for office space, utilities and secretarial and administrative support commencing on January 30, 2026. Upon completion of a Business Combination or its liquidation, the Company will cease paying these monthly fees. For the three and six months ended June 30, 2026, the Company incurred $45,000 and $75,000 in administrative services fees, respectively, of which $75,000 and $0 were included in accrued expenses in the accompanying condensed balance sheets as of June 30, 2026 and December 31, 2025, respectively. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Working Capital Loans&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company&#x2019;s officers and directors may, but are not obligated to, loan the Company funds as may be required (the &#x201c;Working Capital Loans&#x201d;). If the Company completes a Business Combination, the Company would repay the Working Capital Loans. In the event that a Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into private placement units of the post Business Combination entity at a price of $10.00 per unit at the option of the lender. As of June 30, 2026 and December 31, 2025, no such Working Capital Loans were outstanding. &lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="cref_568168168"
      decimals="0"
      id="ixv-5215"
      unitRef="uref_1265451126">6708333</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_1795270125"
      decimals="4"
      id="ixv-5216"
      unitRef="uref_1609687254">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ExchangeFees
      contextRef="cref_977868362"
      decimals="0"
      id="ixv-5217"
      unitRef="uref_1973205255">25000</us-gaap:ExchangeFees>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1795270125"
      decimals="3"
      id="ixv-5218"
      unitRef="uref_1609687254">0.004</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="cref_622567651"
      decimals="0"
      id="ixv-5219"
      unitRef="uref_1265451126">280000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="cref_622567651"
      decimals="0"
      id="ixv-5220"
      unitRef="uref_1265451126">280000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="cref_622567651"
      decimals="0"
      id="ixv-5221"
      unitRef="uref_1973205255">688800</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_581880427"
      decimals="2"
      id="ixv-5222"
      unitRef="uref_1609687254">2.46</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharePrice
      contextRef="cref_581880427"
      decimals="2"
      id="fc_581880427"
      unitRef="uref_1609687254">9.85</us-gaap:SharePrice>
    <muzeu:ThirdPartyValuationMeasurementInput
      contextRef="cref_622567651"
      decimals="3"
      id="ixv-5224"
      unitRef="uref_148446753">0.25</muzeu:ThirdPartyValuationMeasurementInput>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1488990682"
      decimals="2"
      id="ixv-5225"
      unitRef="uref_1609687254">12</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="cref_473022421"
      decimals="0"
      id="ixv-5226"
      unitRef="uref_1973205255">300000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:RepaymentsOfDebt
      contextRef="cref_648891826"
      decimals="0"
      id="ixv-5227"
      unitRef="uref_1973205255">230000</us-gaap:RepaymentsOfDebt>
    <us-gaap:CostsAndExpensesRelatedParty
      contextRef="cref_479704638"
      decimals="0"
      id="ixv-5228"
      unitRef="uref_1973205255">0</us-gaap:CostsAndExpensesRelatedParty>
    <us-gaap:CostsAndExpensesRelatedParty
      contextRef="cref_271155247"
      decimals="0"
      id="ixv-5229"
      unitRef="uref_1973205255">641</us-gaap:CostsAndExpensesRelatedParty>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="cref_1763374762"
      decimals="0"
      id="ixv-5230"
      unitRef="uref_1973205255">15000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:AdministrativeFeesExpense
      contextRef="cref_162999191"
      decimals="0"
      id="ixv-5231"
      unitRef="uref_1973205255">45000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5232"
      unitRef="uref_1973205255">75000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="cref_1216558862"
      decimals="0"
      id="ixv-5233"
      unitRef="uref_1973205255">75000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="cref_714186170"
      decimals="0"
      id="ixv-5234"
      unitRef="uref_1973205255">0</us-gaap:AccruedLiabilitiesCurrent>
    <muzeu:WorkingCapitalLoans
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5235"
      unitRef="uref_1973205255">1500000</muzeu:WorkingCapitalLoans>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="cref_1692292676"
      decimals="2"
      id="ixv-5236"
      unitRef="uref_1609687254">10</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="cref_2122540640" id="ixv-3253">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;6 &#x2014;&#160;Commitments and Contingencies&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company&#x2019;s ability to complete an initial Business Combination may be adversely affected by various factors, many of which are beyond the Company&#x2019;s control. The Company&#x2019;s ability to consummate an initial Business Combination could be impacted by, among other things, changes in laws or regulations, downturns in the financial markets or in economic conditions, inflation, fluctuations in interest rates, increases in tariffs, supply chain disruptions, declines in consumer confidence and spending, public health considerations and geopolitical instability, such as the military conflicts in Ukraine, between the United States, Israel and Iran and others in the Middle East and Southwest Asia or other armed hostilities. The Company cannot at this time predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact the Company&#x2019;s ability to complete an initial Business Combination.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;       &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Registration Rights&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The holders of the Founder Shares, Private Placement Units&#160;and the Class&#160;A Ordinary Shares underlying the Warrants contained in such Private Placement Units&#160;and Units&#160;that may be issued upon conversion of the Working Capital Loans have registration rights to require the Company to register for resale of any of the Company&#x2019;s securities held by them and any other securities of the Company acquired by them prior to the consummation of the initial Business Combination pursuant to a registration rights agreement signed prior to or on the effective date of the Initial Public Offering. The holders of securities having an aggregate value of $25 million are entitled to make up to three demands, excluding short-form demands, that the Company registers such securities. In addition, the holders have certain piggyback registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. Notwithstanding anything to the contrary, BTIG may only make a demand on one occasion and only during the five-year period beginning on the effective date of the Registration Statement. In addition, BTIG may participate in a piggyback registration only during the seven-year period beginning on the effective date of the IPO Registration Statement. The Company will bear the expenses incurred in connection with the filing of any such registration statements. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Underwriting Agreement&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Underwriters had a 45-day option from the date of the Initial Public Offering to purchase up to an additional 2,625,000&#160;units to cover over-allotments, if any. On February 2, 2026, the Underwriters exercised their Over-Allotment Option, closing on the 2,625,000 additional Units simultaneously with the Initial Public Offering. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Underwriters were paid a cash underwriting discount of $0.175 per Unit, or $3,521,875 (the &#x201c;Base Fee&#x201d;). The Underwriters paid the Company an aggregate amount of $503,125 at the closing of the Initial Public Offering as reimbursement to the Company for certain of its expenses and fees incurred in connection with the Initial Public Offering. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Additionally, the Underwriters are entitled to a Deferred Fee of $0.35 per Unit, or up to $7,043,750, payable to the representative on behalf of the Underwriters only upon the consummation of an initial Business Combination. The Deferred Fee will be payable to the representative on behalf of the Underwriters upon the closing of the initial Business Combination in two portions, as follows: (i)&#160;$0.20 per unit sold in the Initial Public Offering shall be paid to the Underwriters in cash, (ii)&#160;up to $0.15 per unit sold in the Initial Public Offering shall be paid to the Underwriters in cash, based on the funds remaining in the Trust Account after giving effect to Class&#160;A Ordinary Shares that are redeemed in connection with an initial Business Combination. &lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <muzeu:SecuritiesAggregateValue
      contextRef="cref_2122540640"
      decimals="-6"
      id="ixv-5237"
      unitRef="uref_1973205255">25000000</muzeu:SecuritiesAggregateValue>
    <muzeu:NumberOfDaysWereGrantedToUnderwriters contextRef="cref_1649110242" id="ixv-5238">P45D</muzeu:NumberOfDaysWereGrantedToUnderwriters>
    <muzeu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1532563924"
      decimals="0"
      id="ixv-5239"
      unitRef="uref_1265451126">2625000</muzeu:UnitsIssuedDuringPeriodSharesNewIssues>
    <muzeu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1056148756"
      decimals="0"
      id="ixv-5240"
      unitRef="uref_1265451126">2625000</muzeu:UnitsIssuedDuringPeriodSharesNewIssues>
    <muzeu:PricePerSharesOfUnderwritingDiscount
      contextRef="cref_197171965"
      decimals="3"
      id="ixv-5241"
      unitRef="uref_1609687254">0.175</muzeu:PricePerSharesOfUnderwritingDiscount>
    <us-gaap:PaymentsForUnderwritingExpense
      contextRef="cref_197171965"
      decimals="0"
      id="fc_197171965"
      unitRef="uref_1973205255">3521875</us-gaap:PaymentsForUnderwritingExpense>
    <us-gaap:PaymentsForUnderwritingExpense
      contextRef="cref_1649110242"
      decimals="0"
      id="ixv-5243"
      unitRef="uref_1973205255">503125</us-gaap:PaymentsForUnderwritingExpense>
    <muzeu:DeferredUnderwritingDiscountPrice
      contextRef="cref_1649110242"
      decimals="2"
      id="ixv-5244"
      unitRef="uref_1609687254">0.35</muzeu:DeferredUnderwritingDiscountPrice>
    <muzeu:DeferredUnderwritingDiscount
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5245"
      unitRef="uref_1973205255">7043750</muzeu:DeferredUnderwritingDiscount>
    <muzeu:NumberOfSoldUnitPrice
      contextRef="cref_81139869"
      decimals="2"
      id="ixv-5246"
      unitRef="uref_1609687254">0.2</muzeu:NumberOfSoldUnitPrice>
    <muzeu:NumberOfSoldUnitPrice
      contextRef="cref_1649110242"
      decimals="2"
      id="ixv-5247"
      unitRef="uref_1609687254">0.15</muzeu:NumberOfSoldUnitPrice>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="cref_2122540640" id="ixv-3285">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;7 &#x2014;&#160;Shareholders&#x2019; Deficit&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; &lt;span style="font-weight: bold;"&gt;&lt;i&gt;Preference Shares&lt;/i&gt;&lt;/span&gt; &#x2014; The Company is authorized to issue a total of 1,000,000 preference shares at par value of $0.0001. At June 30, 2026 and December 31, 2025, there were &lt;span style="-sec-ix-hidden:fc_1170507871;"&gt;&lt;span style="-sec-ix-hidden:fc_175899818;"&gt;&lt;span style="-sec-ix-hidden:fc_1466601224;"&gt;&lt;span style="-sec-ix-hidden:fc_1634110681;"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; preference shares issued or outstanding. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; &lt;span style="font-weight: bold;"&gt;&lt;i&gt;Class&#160;A Ordinary Shares&#160;&lt;/i&gt;&lt;/span&gt;&#x2014;&#160;The Company is authorized to issue a total of 450,000,000 Class&#160;A Ordinary Shares at par value of $0.0001 per share. At June 30, 2026 and December 31, 2025, there were 486,875 and &lt;span style="-sec-ix-hidden:fc_555309476;"&gt;&lt;span style="-sec-ix-hidden:fc_2092829611;"&gt;no&lt;/span&gt;&lt;/span&gt; Class&#160;A Ordinary Shares issued and outstanding, excluding 20,125,000 and &lt;span style="-sec-ix-hidden:fc_935895049;"&gt;0&lt;/span&gt; Class A Ordinary Shares subject to possible redemption, respectively. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; &lt;span style="font-weight: bold;"&gt;&lt;i&gt;Class&#160;B Ordinary Shares&#160;&lt;/i&gt;&lt;/span&gt;&#x2014;&#160;The Company is authorized to issue a total of 49,000,000 Class&#160;B Ordinary Shares at par value of $0.0001 per share. At June 30, 2026 and December 31, 2025, there were 6,708,333 Class B Ordinary Shares issued and outstanding. On October 22, 2025, the Company issued an aggregate of 6,708,333 Founder Shares in exchange for a $25,000 payment (approximately $0.004 per share) from the Sponsor to cover certain expenses on behalf of the Company. The Founder Shares included an aggregate of up to 875,000 shares subject to forfeiture if the Over-Allotment Option was not exercised by the Underwriters in full. As a result of the Underwriters&#x2019; election to fully exercise the Over-Allotment Option on February 2, 2026, 875,000 Founder Shares are no longer subject to forfeiture by the Sponsor. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Founder Shares will automatically convert into Class&#160;A Ordinary Shares concurrently with or immediately following the consummation of the initial Business Combination or earlier at the option of the holder on a one-for-one basis, subject to adjustment for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class&#160;A Ordinary Shares, or any other equity-linked securities, are issued or deemed issued in excess of the amounts sold in the Initial Public Offering and related to or in connection with the closing of the initial Business Combination, the ratio at which Class&#160;B Ordinary Shares convert into Class&#160;A Ordinary Shares will be adjusted (unless the holders of a majority of the outstanding Class&#160;B Ordinary Shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class&#160;A Ordinary Shares issuable upon conversion of all Class&#160;B Ordinary Shares will equal, in the aggregate, approximately 25% of the sum of (i)&#160;the total number of all Class&#160;A Ordinary Shares outstanding upon the completion of the Initial Public Offering (including any Class&#160;A Ordinary Shares issued pursuant to the Underwriters&#x2019; Over-Allotment Option and excluding the Class&#160;A Ordinary Shares underlying the Warrants contained in the private placement units), plus (ii)&#160;all Class&#160;A Ordinary Shares and equity-linked securities issued or deemed issued, in connection with the closing of the initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination and any private placement-equivalent warrants issued to our sponsor or any of its affiliates or to our officers or directors upon conversion of working capital loans) minus (iii)&#160;any redemptions of Class&#160;A Ordinary Shares by public shareholders in connection with an initial business combination; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;       &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Holders of record of the Company&#x2019;s Class&#160;A Ordinary Shares and Class&#160;B Ordinary Shares are entitled to one vote for each share held on all matters to be voted on by shareholders. Unless specified in the amended and restated memorandum and articles of association or as required by the Companies Act or stock exchange rules, an ordinary resolution under Cayman Islands law and the amended and restated memorandum and articles of association, which requires the affirmative vote of at least a majority of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting of the Company is generally required to approve any matter voted on by our shareholders. Approval of certain actions requires a special resolution under Cayman Islands law, which (except as specified below) requires the affirmative vote of at least two-thirds of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting, and pursuant to the amended and restated memorandum and articles of association, such actions include amending our amended and restated memorandum and articles of association and approving a statutory merger or consolidation with another company. There is no cumulative voting with respect to the appointment of directors, meaning, following our initial business combination, the holders of more than 50% of the ordinary shares voted for the appointment of directors can elect all of the directors. Prior to the consummation of the initial Business Combination, only holders of the Class&#160;B Ordinary Shares will (i)&#160;have the right to vote on the appointment and removal of directors and (ii)&#160;be entitled to vote on continuing our company in a jurisdiction outside the Cayman Islands (including any special resolution required to amend the constitutional documents or to adopt new constitutional documents, in each case, as a result of our approving a transfer by way of continuation in a jurisdiction outside the Cayman Islands). Holders of the Class&#160;A Ordinary Shares will not be entitled to vote on these matters during such time. These provisions of the amended and restated memorandum and articles of association may only be amended if approved by a special resolution passed by the affirmative vote of at least 90% (or, where such amendment is proposed in respect of the consummation of the initial Business Combination, two-thirds) of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting of the Company. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; &lt;span style="font-weight: bold;"&gt;&lt;i&gt;Warrants&lt;/i&gt;&#160;&#x2014;&#160;&lt;/span&gt;There are 10,062,500 Public Warrants and 243,438 Private Placement Warrants currently outstanding as of June 30, 2026. There were &lt;span style="-sec-ix-hidden:fc_112120139;"&gt;&lt;span style="-sec-ix-hidden:fc_1455913599;"&gt;no&lt;/span&gt;&lt;/span&gt; Public Warrants and Private Placement Warrants outstanding as of December 31, 2025. Each whole warrant entitles the holder to purchase one Class&#160;A Ordinary Share at a price of $11.50 per share, subject to adjustment as discussed herein. The warrants cannot be exercised until 30&#160;days after the completion of the initial Business Combination, and will expire at 5:00&#160;p.m., New&#160;York City time, five&#160;years after the completion of the initial Business Combination or earlier upon redemption or liquidation. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The Company will not be obligated to deliver any Class&#160;A Ordinary Shares pursuant to the exercise of a Warrant and will have no obligation to settle such Warrant exercise unless a registration statement under the Securities Act with respect to the Class&#160;A Ordinary Shares underlying the Warrants is then effective and a prospectus relating thereto is current. No Warrant will be exercisable and the Company will not be obligated to issue a Class&#160;A Ordinary Share upon exercise of a Warrant unless the Class&#160;A Ordinary Share issuable upon such Warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the Warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a Warrant, the holder of such Warrant will not be entitled to exercise such Warrant and such Warrant may have no value and expire worthless. In no event will the Company be required to net cash settle any Warrant. In the event that a registration statement is not effective for the exercised Warrants, the purchaser of a unit containing such warrant will have paid the full purchase price for the unit solely for the Class&#160;A Ordinary Share underlying such unit.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; Under the terms of the warrant agreement, the Company has agreed that, as soon as practicable, but in no event later than 20&#160;business&#160;days, after the closing of its Business Combination, it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement for the Initial Public Offering or a new registration statement covering the registration under the Securities Act&#160;of&#160;the Class&#160;A Ordinary Shares issuable upon exercise of the Warrants and thereafter will use its commercially reasonable efforts to cause the same to become effective within 60&#160;business&#160;days following the Company&#x2019;s initial Business Combination and to maintain a current prospectus relating to the Class&#160;A Ordinary Shares issuable upon exercise of the Warrants until the expiration of the Warrants in accordance with the provisions of the Warrant Agreement. If a registration statement covering the Class&#160;A Ordinary Shares issuable upon exercise of the Warrants is not effective by the sixtieth (60&lt;sup&gt;th&lt;/sup&gt;) business&#160;day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise Warrants on a &#x201c;cashless basis&#x201d; in accordance with Section&#160;3(a)(9)&#160;of the Securities Act or another exemption. Notwithstanding the above, if the Class&#160;A Ordinary Shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a &#x201c;covered security&#x201d; under Section&#160;18(b)(1)&#160;of the Securities Act, the Company may, at its option, require holders of public Warrants who exercise their Warrants to do so on a &#x201c;cashless basis&#x201d; in accordance with Section&#160;3(a)(9)&#160;of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect and does not so file or maintain such registration statement, the Company will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;       &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; If the holders exercise their Public Warrants on a cashless basis, they would pay the warrant exercise price by surrendering the warrants for that number of Class&#160;A Ordinary Shares equal to the quotient obtained by dividing (x)&#160;the product of the number of Class&#160;A Ordinary Shares underlying the Warrants, multiplied by the excess of the &#x201c;fair market value&#x201d; of the Class&#160;A Ordinary Shares over the exercise price of the warrants by (y)&#160;the fair market value. The &#x201c;fair market value&#x201d; is the average reported closing price of the Class&#160;A Ordinary Shares for the 10&#160;trading&#160;days ending on the third&#160;trading&#160;day prior to the date on which the notice of exercise is received by the warrant agent or on which the notice of redemption is sent to the holders of Warrants, as applicable. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; &lt;i&gt;Redemption of Warrants When the Price per Class&#160;A Ordinary Share Equals or Exceeds $18.00&lt;/i&gt;:&#160;&#160;&#160;&#160;The Company may redeem the outstanding warrants: &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 17.45pt;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify;"&gt;&lt;td style="width: 0.25in;"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;in whole and not in part;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 17.45pt;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify;"&gt;&lt;td style="width: 0.25in;"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;at a price of $0.01 per warrant;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 17.45pt;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify;"&gt;&lt;td style="width: 0.25in;"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;upon a minimum of 30&#160;days&#x2019; prior written notice of redemption (the &#x201c;30-day redemption period&#x201d;); and&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 17.45pt;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify;"&gt;&lt;td style="width: 0.25in;"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;if, and only if, the closing price of the Class&#160;A Ordinary Shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any 20&#160;trading&#160;days within a 30-trading&#160;day period commencing at least 30&#160;days after completion of our initial business combination and ending three&#160;business&#160;days before the Company sends the notice of redemption to the warrant holders.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Additionally, if the number of outstanding Class&#160;A Ordinary Shares is increased by a share capitalization payable in Class&#160;A Ordinary Shares, or by a subdivision of ordinary shares or other similar event, then, on the effective date of such share capitalization, subdivision or similar event, the number of Class&#160;A Ordinary Shares issuable on exercise of each warrant will be increased in proportion to such increase in the outstanding ordinary shares. A rights offering made to all or substantially all holders of ordinary shares entitling holders to purchase Class&#160;A Ordinary Shares at a price less than the fair market value will be deemed a share capitalization of a number of Class&#160;A Ordinary Shares equal to the product of (i)&#160;the number of Class&#160;A Ordinary Shares actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for Class&#160;A Ordinary Shares) and (ii)&#160;the quotient of (x)&#160;the price per Class&#160;A Ordinary Share paid in such rights offering and (y)&#160;the fair market value. For these purposes (i)&#160;if the rights offering is for securities convertible into or exercisable for Class&#160;A Ordinary Shares, in determining the price payable for Class&#160;A Ordinary Shares, there will be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii)&#160;fair market value means the volume weighted average price of Class&#160;A Ordinary Shares as reported during the ten (10)&#160;trading&#160;day period ending on the&#160;trading&#160;day prior to the first date on which the Class&#160;A Ordinary Shares trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-5248"
      unitRef="uref_1265451126">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="cref_1335135677"
      decimals="4"
      id="ixv-5249"
      unitRef="uref_1609687254">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_2081978511"
      decimals="0"
      id="ixv-5250"
      unitRef="uref_1265451126">450000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_2081978511"
      decimals="4"
      id="ixv-5251"
      unitRef="uref_1609687254">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_2081978511"
      decimals="0"
      id="ixv-5252"
      unitRef="uref_1265451126">486875</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_2081978511"
      decimals="0"
      id="ixv-5253"
      unitRef="uref_1265451126">486875</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="cref_2081978511"
      decimals="0"
      id="ixv-5254"
      unitRef="uref_1265451126">20125000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_1267833943"
      decimals="0"
      id="ixv-5255"
      unitRef="uref_1265451126">49000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_1267833943"
      decimals="4"
      id="ixv-5256"
      unitRef="uref_1609687254">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_1267833943"
      decimals="0"
      id="ixv-5257"
      unitRef="uref_1265451126">6708333</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_1267833943"
      decimals="0"
      id="ixv-5258"
      unitRef="uref_1265451126">6708333</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_349501735"
      decimals="0"
      id="ixv-5259"
      unitRef="uref_1265451126">6708333</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_349501735"
      decimals="0"
      id="ixv-5260"
      unitRef="uref_1265451126">6708333</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1711580487"
      decimals="0"
      id="ixv-5261"
      unitRef="uref_1265451126">6708333</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_568168168"
      decimals="0"
      id="ixv-5262"
      unitRef="uref_1973205255">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1795270125"
      decimals="3"
      id="ixv-5263"
      unitRef="uref_1609687254">0.004</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="cref_1503047126"
      decimals="0"
      id="ixv-5264"
      unitRef="uref_1265451126">875000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="cref_1503047126"
      decimals="0"
      id="ixv-5265"
      unitRef="uref_1265451126">875000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="cref_1581440693"
      decimals="2"
      id="ixv-5266"
      unitRef="uref_148446753">0.25</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <muzeu:MinimumPercentageOfVoteForElectionOfDirectors
      contextRef="cref_2122540640"
      decimals="2"
      id="ixv-5267"
      unitRef="uref_148446753">0.50</muzeu:MinimumPercentageOfVoteForElectionOfDirectors>
    <muzeu:PercentageOfVotingShareholders
      contextRef="cref_2122540640"
      decimals="2"
      id="ixv-5268"
      unitRef="uref_148446753">0.90</muzeu:PercentageOfVotingShareholders>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_758136669"
      decimals="0"
      id="fc_758136669"
      unitRef="uref_1265451126">10062500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_1265451126"
      decimals="0"
      id="fc_1265451126"
      unitRef="uref_1265451126">243438</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_479835142"
      decimals="2"
      id="ixv-5271"
      unitRef="uref_1609687254">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <muzeu:NumberOfTradingDaysCommencing contextRef="cref_6201542" id="ixv-5272">P30D</muzeu:NumberOfTradingDaysCommencing>
    <muzeu:BusinessDaysAfterClosingTheInitialBusinessCombination contextRef="cref_2122540640" id="ixv-5273">P20D</muzeu:BusinessDaysAfterClosingTheInitialBusinessCombination>
    <muzeu:EffectiveWithInBusinessDaysFollowingTheInitialBusinessCombination contextRef="cref_2122540640" id="ixv-5274">P60D</muzeu:EffectiveWithInBusinessDaysFollowingTheInitialBusinessCombination>
    <muzeu:NumberOfTradingDays contextRef="cref_2122540640" id="ixv-5275">P10D</muzeu:NumberOfTradingDays>
    <muzeu:ClassOfWarrantOrRightRedemptionPriceOfWarrants
      contextRef="cref_765416459"
      decimals="2"
      id="ixv-5276"
      unitRef="uref_1609687254">18</muzeu:ClassOfWarrantOrRightRedemptionPriceOfWarrants>
    <muzeu:ClassOfWarrantOrRightRedemptionPriceOfWarrants
      contextRef="cref_6201542"
      decimals="2"
      id="ixv-5277"
      unitRef="uref_1609687254">0.01</muzeu:ClassOfWarrantOrRightRedemptionPriceOfWarrants>
    <muzeu:PriorWrittenNoticeOfRedemption contextRef="cref_2122540640" id="ixv-5278">P30D</muzeu:PriorWrittenNoticeOfRedemption>
    <muzeu:ClassOfWarrantOrRightRedemptionPriceOfWarrants
      contextRef="cref_2122540640"
      decimals="2"
      id="ixv-5279"
      unitRef="uref_1609687254">18</muzeu:ClassOfWarrantOrRightRedemptionPriceOfWarrants>
    <muzeu:NumberOfTradingDaysForDeterminingTheNewlyIssuedSharePrice contextRef="cref_2122540640" id="ixv-5280">P20D</muzeu:NumberOfTradingDaysForDeterminingTheNewlyIssuedSharePrice>
    <muzeu:NumberOfConsecutiveTradingDaysForDeterminingTheNewlyIssuedSharePrice contextRef="cref_2122540640" id="ixv-5281">P30D</muzeu:NumberOfConsecutiveTradingDaysForDeterminingTheNewlyIssuedSharePrice>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="cref_2122540640" id="ixv-3389">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Note 8 &#x2014;&#160;Fair Value Measurements&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 19.4pt;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;Fair value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-align: justify; text-indent: -14.6pt;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify;"&gt;&lt;td style="width: 0.25in;"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;Level&#160;1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-align: justify; text-indent: -14.6pt;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify;"&gt;&lt;td style="width: 0.25in;"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;Level&#160;2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.15pt; text-align: justify; text-indent: -14.6pt;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt;&lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify;"&gt;&lt;td style="width: 0.25in;"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;Level&#160;3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 19.4pt;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 14.55pt;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The following table presents information about the Company&#x2019;s assets that are measured at fair value on a recurring basis at June 30, 2026 and December 31, 2025 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid;"&gt;Description&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;June 30,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 64%; text-align: justify;"&gt;Investments held in Trust Account&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: center;"&gt;1&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;204,176,777&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;*&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_680511691;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify;"&gt;&lt;td style="width: 0in;"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;*&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;includes accrued interest amounting to $597,589.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 19.4pt;"&gt;&#160;&lt;/p&gt;  &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The fair value as of date of the Public Warrants issued in the Initial Public Offering was $2,918,125, or $0.29 per Public Warrant. The Public Warrants issued in the Initial Public Offering have been classified within shareholders&#x2019; equity and will not require remeasurement after issuance. The fair value of the Public Warrants was calculated utilizing a Monte Carlo simulation. The following table presents the quantitative information regarding market assumptions used in the Level 3 valuation of the Public Warrants issued in the Initial Public Offering: &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 14.55pt;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;February&#160;2,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 88%; text-align: justify; text-indent: -5.85pt; padding-left: 5.85pt;"&gt;Expected term to de-SPAC (years)&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;2.0&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: justify; text-indent: -5.85pt; padding-left: 5.85pt;"&gt;Probability of de-SPAC and instrument-specific market adjustment&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;25.0&lt;/td&gt; &lt;td style="text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: justify; text-indent: -5.85pt; padding-left: 5.85pt;"&gt;Risk-free rate (continuous)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;4.01&lt;/td&gt; &lt;td style="text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: justify; text-indent: -5.85pt; padding-left: 5.85pt;"&gt;Implied Class A share price&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;9.85&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="cref_2122540640" id="ixv-3424">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The following table presents information about the Company&#x2019;s assets that are measured at fair value on a recurring basis at June 30, 2026 and December 31, 2025 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid;"&gt;Description&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;June 30,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 64%; text-align: justify;"&gt;Investments held in Trust Account&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: center;"&gt;1&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;204,176,777&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;*&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_680511691;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify;"&gt;&lt;td style="width: 0in;"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;*&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;includes accrued interest amounting to $597,589.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_655671550"
      decimals="0"
      id="fc_655671550"
      unitRef="uref_1973205255">204176777</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-5283"
      unitRef="uref_1973205255">597589</us-gaap:InterestPayableCurrentAndNoncurrent>
    <muzeu:FairValueOfPublicRights
      contextRef="cref_508943013"
      decimals="0"
      id="ixv-5284"
      unitRef="uref_1973205255">2918125</muzeu:FairValueOfPublicRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_1609687254"
      decimals="2"
      id="ixv-5285"
      unitRef="uref_1609687254">0.29</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="cref_2122540640" id="ixv-5286">The following table presents the quantitative information regarding market assumptions used in the Level 3 valuation of the Public Warrants issued in the Initial Public Offering:&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;February&#160;2,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 88%; text-align: justify; text-indent: -5.85pt; padding-left: 5.85pt;"&gt;Expected term to de-SPAC (years)&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;2.0&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: justify; text-indent: -5.85pt; padding-left: 5.85pt;"&gt;Probability of de-SPAC and instrument-specific market adjustment&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;25.0&lt;/td&gt; &lt;td style="text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: justify; text-indent: -5.85pt; padding-left: 5.85pt;"&gt;Risk-free rate (continuous)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;4.01&lt;/td&gt; &lt;td style="text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: justify; text-indent: -5.85pt; padding-left: 5.85pt;"&gt;Implied Class A share price&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;9.85&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_1616795263"
      decimals="1"
      id="ixv-5287"
      unitRef="uref_148446753">2</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_1592048696"
      decimals="3"
      id="ixv-5288"
      unitRef="uref_148446753">0.25</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_109758591"
      decimals="4"
      id="ixv-5289"
      unitRef="uref_148446753">0.0401</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_148446753"
      decimals="2"
      id="ixv-5290"
      unitRef="uref_148446753">9.85</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="cref_2122540640" id="ixv-3510">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;9&#160;&#x2014;&#160;Segment Information&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;FASB ASC Topic&#160;280, &#x201c;Segment Reporting,&#x201d; establishes standards for companies to report in their unaudited condensed financial statements information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the Company&#x2019;s chief operating decision maker, or group, in deciding how to allocate resources and assess performance.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The Company&#x2019;s chief operating decision maker (&#x201c;CODM&#x201d;) has been identified as the &lt;span style="-sec-ix-hidden:fc_665769053;"&gt;Chief Executive Officer&lt;/span&gt;, who reviews the assets, operating results and financial metrics for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has &lt;span style="-sec-ix-hidden:fc_323860442;"&gt;one&lt;/span&gt; reportable segment. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt; The CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on the unaudited condensed statements of operations as net income or loss. The measure of segment assets is reported on the condensed balance sheets as total assets. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;When evaluating the Company&#x2019;s performance and making key decisions regarding resource allocation the CODM reviews several key metrics, which include the following:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;June 30,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;December 31,&lt;br/&gt; 2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;Cash and cash equivalents&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;839,267&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;69&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Investments held in Trust Account&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;204,176,777&lt;/td&gt; &lt;td style="text-align: left;"&gt;*&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_875046747;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="width: 3%; padding-right: 0.8pt; font-size: 10pt;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;*&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 97%; padding-right: 0.8pt; text-align: justify; font-size: 10pt;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;includes accrued interest (interest that has been earned but not yet received) amounting to $597,589.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;For the&lt;br/&gt; Three Months Ended&lt;br/&gt; June 30,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;For the&lt;br/&gt; Six Months Ended&lt;br/&gt; June 30,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;General and administrative expenses&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;147,265&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;352,495&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; text-indent: -5.85pt; padding-left: 5.85pt;"&gt;Interest earned on investments held in Trust Account&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;1,802,635&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;2,926,777&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;The key metrics included in segment profit or loss reviewed by the CODM are interest earned on investments held in Trust Account and General and administrative expenses. The CODM reviews interest earned on investments held in the Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the trust agreement. General and administrative expenses are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a Business Combination within the Combination Period. The CODM also reviews general and administrative expenses to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;General and administrative expenses, as reported on the unaudited condensed statements of operations, are the significant segment expenses provided to the CODM on a regular basis. All other segment items included in net income or loss are reported on the unaudited condensed statements of operations and described within their respective disclosures.&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription contextRef="cref_2122540640" id="ixv-3517">The Company&#x2019;s chief operating decision maker (&#x201c;CODM&#x201d;) has been identified as the Chief Executive Officer, who reviews the assets, operating results and financial metrics for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one reportable segment.The CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on the unaudited condensed statements of operations as net income or loss. The measure of segment assets is reported on the condensed balance sheets as total assets.</us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription>
    <us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock contextRef="cref_2122540640" id="ixv-3524">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;When evaluating the Company&#x2019;s performance and making key decisions regarding resource allocation the CODM reviews several key metrics, which include the following:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;June 30,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;December 31,&lt;br/&gt; 2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;Cash and cash equivalents&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;839,267&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;69&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Investments held in Trust Account&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;204,176,777&lt;/td&gt; &lt;td style="text-align: left;"&gt;*&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_875046747;"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="width: 3%; padding-right: 0.8pt; font-size: 10pt;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;*&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 97%; padding-right: 0.8pt; text-align: justify; font-size: 10pt;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"&gt;includes accrued interest (interest that has been earned but not yet received) amounting to $597,589.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="cref_1335135677"
      decimals="0"
      id="ixv-5292"
      unitRef="uref_1973205255">839267</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="cref_583273791"
      decimals="0"
      id="ixv-5293"
      unitRef="uref_1973205255">69</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AssetsHeldInTrust
      contextRef="cref_1335135677"
      decimals="0"
      id="fc_563224654"
      unitRef="uref_1973205255">204176777</us-gaap:AssetsHeldInTrust>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="cref_1335135677"
      decimals="0"
      id="fc_1335135677"
      unitRef="uref_1973205255">597589</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock contextRef="cref_2122540640" id="ixv-3570">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;For the&lt;br/&gt; Three Months Ended&lt;br/&gt; June 30,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;For the&lt;br/&gt; Six Months Ended&lt;br/&gt; June 30,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;General and administrative expenses&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;147,265&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;352,495&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; text-indent: -5.85pt; padding-left: 5.85pt;"&gt;Interest earned on investments held in Trust Account&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;1,802,635&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;$&lt;/td&gt; &lt;td style="text-align: right;"&gt;2,926,777&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_278843630"
      decimals="0"
      id="ixv-5296"
      unitRef="uref_1973205255">147265</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5297"
      unitRef="uref_1973205255">352495</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_278843630"
      decimals="0"
      id="ixv-5298"
      unitRef="uref_1973205255">1802635</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_2122540640"
      decimals="0"
      id="ixv-5299"
      unitRef="uref_1973205255">2926777</us-gaap:InvestmentIncomeInterest>
    <us-gaap:SubsequentEventsTextBlock contextRef="cref_2122540640" id="ixv-3613">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;10 &#x2014;&#160;Subsequent Events&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white;"&gt;The Company evaluated subsequent events and transactions that occurred after the condensed balance sheet date through the date that the unaudited condensed financial statements were available to be issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="cref_278843630" id="ixv-5300">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="cref_278843630" id="ixv-5301">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="cref_278843630" id="ixv-5302">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="cref_278843630" id="ixv-5303">false</ecd:NonRule10b51ArrTrmntdFlag>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#fc_1426911310"
          xlink:label="fc_1426911310"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1790904166"
          xlink:label="fc_1790904166"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_24014286"
          xlink:label="fc_24014286"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_3285224"
          xlink:label="fc_3285224"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_262493807"
          xlink:label="fc_262493807"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_995691432"
          xlink:label="fc_995691432"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1757798184"
          xlink:label="fc_1757798184"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_2005313810"
          xlink:label="fc_2005313810"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1359902912"
          xlink:label="fc_1359902912"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1515654518"
          xlink:label="fc_1515654518"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_507600924"
          xlink:label="fc_507600924"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_935728785"
          xlink:label="fc_935728785"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_2066066376"
          xlink:label="fc_2066066376"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1950159288"
          xlink:label="fc_1950159288"
          xlink:type="locator"/>
        <link:footnote id="fref_1345403458" xlink:label="fref_1345403458" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">As     of December 31, 2025, includes up to 875,000 Class&#160;B Ordinary Shares that were subject to forfeiture if the Over-Allotment     Option was not exercised in full or in part by the Underwriters. On February 2, 2026, the Underwriters exercised their     Over-Allotment Option in full to be settled as part of the closing of the Initial Public Offering. As a result of the     Underwriters&#x2019; election to fully exercise their Over-Allotment Option, 875,000 Founder Shares are no longer subject to     forfeiture by the Sponsor (see Note 7).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1426911310"
          xlink:to="fref_1345403458"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1790904166"
          xlink:to="fref_1345403458"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_24014286"
          xlink:to="fref_1345403458"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_3285224"
          xlink:to="fref_1345403458"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_262493807"
          xlink:to="fref_1345403458"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_995691432"
          xlink:to="fref_1345403458"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1757798184"
          xlink:to="fref_1345403458"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_2005313810"
          xlink:to="fref_1345403458"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1359902912"
          xlink:to="fref_1345403458"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1515654518"
          xlink:to="fref_1345403458"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_507600924"
          xlink:to="fref_1345403458"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_935728785"
          xlink:to="fref_1345403458"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_2066066376"
          xlink:to="fref_1345403458"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1950159288"
          xlink:to="fref_1345403458"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_522679048"
          xlink:label="fc_522679048"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_113126255"
          xlink:label="fc_113126255"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_186863080"
          xlink:label="fc_186863080"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1596679236"
          xlink:label="fc_1596679236"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_123956521"
          xlink:label="fc_123956521"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1895070928"
          xlink:label="fc_1895070928"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1603811698"
          xlink:label="fc_1603811698"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1602752913"
          xlink:label="fc_1602752913"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_2061447008"
          xlink:label="fc_2061447008"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_605294596"
          xlink:label="fc_605294596"
          xlink:type="locator"/>
        <link:footnote id="fref_1068457133" xlink:label="fref_1068457133" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes     up to 875,000 Class&#160;B Ordinary Shares that were subject to forfeiture if the Over-Allotment Option is not exercised in full or     in part by the Underwriters. On February 2, 2026, the Underwriters exercised their Over-Allotment Option in full to be settled as     part of the closing of the Initial Public Offering. As a result of the Underwriters&#x2019; election to fully exercise their     Over-Allotment Option, 875,000 Founder Shares are no longer subject to forfeiture by the Sponsor (see Note 7).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_522679048"
          xlink:to="fref_1068457133"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_113126255"
          xlink:to="fref_1068457133"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_186863080"
          xlink:to="fref_1068457133"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1596679236"
          xlink:to="fref_1068457133"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_123956521"
          xlink:to="fref_1068457133"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1895070928"
          xlink:to="fref_1068457133"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1603811698"
          xlink:to="fref_1068457133"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1602752913"
          xlink:to="fref_1068457133"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_2061447008"
          xlink:to="fref_1068457133"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_605294596"
          xlink:to="fref_1068457133"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_695229873"
          xlink:label="fc_695229873"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1173920975"
          xlink:label="fc_1173920975"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_529543847"
          xlink:label="fc_529543847"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_238064799"
          xlink:label="fc_238064799"
          xlink:type="locator"/>
        <link:footnote id="fref_1407894440" xlink:label="fref_1407894440" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes     up to 875,000 Class&#160;B Ordinary Shares that were subject to forfeiture if the Over-Allotment Option was not exercised in full or     in part by the Underwriters. On February 2, 2026, the Underwriters exercised their Over-Allotment Option in full to be settled as     part of the closing of the Initial Public Offering. As a result of the Underwriters&#x2019; election to fully exercise their     Over-Allotment Option, 875,000 Founder Shares are no longer subject to forfeiture by the Sponsor (see Note 7).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_695229873"
          xlink:to="fref_1407894440"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1173920975"
          xlink:to="fref_1407894440"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_529543847"
          xlink:to="fref_1407894440"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_238064799"
          xlink:to="fref_1407894440"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_875046747"
          xlink:label="fc_875046747"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_655671550"
          xlink:label="fc_655671550"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_563224654"
          xlink:label="fc_563224654"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_680511691"
          xlink:label="fc_680511691"
          xlink:type="locator"/>
        <link:footnote id="fref_1618831371" xlink:label="fref_1618831371" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:table
  cellpadding="0"
  cellspacing="0"
  style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse;"><xhtml:tbody><xhtml:tr style="vertical-align: top;"><xhtml:td style="width: 3%; padding-right: 0.8pt; font-size: 10pt;"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">*</xhtml:span></xhtml:td><xhtml:td style="width: 97%; padding-right: 0.8pt; text-align: justify; font-size: 10pt;"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">includes accrued interest (interest that has been earned but not yet received) amounting to $597,589.</xhtml:span></xhtml:td></xhtml:tr></xhtml:tbody></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_875046747"
          xlink:to="fref_1618831371"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_655671550"
          xlink:to="fref_1618831371"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_563224654"
          xlink:to="fref_1618831371"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_680511691"
          xlink:to="fref_1618831371"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
